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ABSTRACT
BRENNA M DOHENY. Estrogen signaling and endocrine disruption potential in the 
embryonic development of the female reproductive tract of the American alligator, 
Alligator mississippiensis. (Under the direction of LOUIS J. GUILLETTE, JR. and 
SHERINE S.L. CHAN).
Perturbation of endocrine signaling during critical embryonic developmental 
windows has been implicated in many female reproductive system disorders. 
Reproductive tract anomalies in women exposed in utero to synthetic estrogen 
diethylstilbestrol, prescribed as a miscarriage preventative, provided some of the first 
evidence for this “embryonic origins of adult disease” paradigm and suggested a role for 
estrogen signaling in female reproductive tract (FRT) differentiation. 
Developmental studies of FRT in other vertebrates have great value in furthering 
our understanding of embryonic origins of reproductive disorders. The alligator is a 
particularly intriguing model as an environmental sentinel species with temperature 
dependent sex determination, which allows for controlled manipulation of sexual 
differentiation in laboratory experiments. The signals involved in determining regionally 
specific cell fates in FRT of alligators and other crocodilians are not yet known, but 
multiple studies in their closest extant evolutionary relative, birds, underscore the role of 
estrogen signaling in this process. 
Here I seek to characterize the role of estrogen signaling in the developing 
alligator FRT. I treated alligator embryos with estradiol-17β (E2) and pharmaceutical 
agonists that are selective for their two estrogen receptor isoforms, ERα and ERβ. 
The ERα agonist, propyl pyrazole triol (PPT), induced significant enlargement of the 
developing FRT, compared with controls and E2 and ERβ agonist treatments. Histological 
analysis revealed precocious glandulogenesis and connective tissue differentiation 
similar to mature FRT in these enlarged tissues. PPT treatment also altered expression of 





At the heart of this dissertation is my underlying interest in the field of 
environmental endocrine disruption, which synergizes reproductive and developmental 
biology and endocrinology and has direct, far-reaching impacts on environmental 
health. The concept of environmental endocrine disruption arose when a growing 
scientific literature on reproductive impairments in both humans and wildlife led a 
trans-disciplinary group of experts to come together at a meeting in 1991 known as the 
Wingspread Work Session. Their consensus statement laid out the founding principles: 
that developmental exposure to hormonally active agents could disrupt normal 
developmental patterning at structural and functional levels that lead to disorders of the 
adult reproductive system (Colborn et al., 1992; Colborn et al., 1996).
The major human health evidence for this “developmental origins of adult 
disease” paradigm came in large part from the unanticipated adverse effects of a synthetic 
estrogen, diethylstilbestrol (DES), used as a miscarriage preventative from 1947-1971 
(United States Centers for Disease Control and Prevention, 2011). This usage ceased 
when it was found that young women who were exposed in utero to DES developed 
an otherwise extremely rare cancer only found in much older women, vaginal clear 
cell adenocarcinoma (Herbst et al., 1971).  Other structural disorders of the female 
reproductive tract (FRT) have been found in these “DES daughters,” such as T-shaped 
uterus and vaginal adenosis, and these women face great difficulties in achieving and 
maintaining successful pregnancies (reviewed in Bern, 1992; Crain et al., 2008; Newbold, 
2004). 
DES exposure-induced FRT disorders are rooted in disruption of the normal 
differentiation of the embryonic Müllerian duct (MD) into specialized FRT regional 
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structures, the Fallopian tubes, uterus and upper vagina. Laboratory studies in mice 
have recapitulated the FRT disorders seen in human DES daughters, and have provided 
insight into the mechanisms underlying FRT disruptions due to embryonic DES exposure 
(reviewed in Newbold, 2004). 
While laboratory models are essential for understanding the mechanisms 
underlying environmental endocrine disruption, wildlife models, exposed to real-world 
levels of environmental endocrine disrupting contaminants (EDCs) through various 
routes and in various mixtures, are equally critical for understanding potential health 
impacts. It was while reviewing studies on the effects of contaminants on wildlife in the 
Great Lakes region that Theo Colborn formulated the ideas that birthed the endocrine 
disruption hypothesis and led her to organize the Wingspread Work Session (Colborn et 
al., 1996).
The American alligator emerged as a particularly valuable wildlife model due 
to a discovery not unlike the story of DES exposure in humans. A severe population 
decline in alligators living in Lake Apopka, FL, following a major spill of the pesticide 
dichlorodiphenyltrichloroethane (DDT) in 1980, led to the recruitment of Louis J. 
Guillette, Jr., by the Florida Fish and Wildlife Conservation Commission (then Florida 
Game and Freshwater Fish Commission) to investigate this anomalous population, as 
well as overarching questions of alligator reproductive biology. 
By comparing alligators in Lake Apopka with alligator populations in more 
pristine Florida lakes, Dr. Guillette’s research group and collaborators established that 
Apopka alligators had higher serum, tissue and egg yolk levels of many contaminants, 
most notably DDT metabolite p,p’-dichlorodiphenyldichloroethylene (DDE) (reviewed 
in Woodward et al., 2011). Experiments involving field collection of eggs and controlled 
incubation in the laboratory showed that Apopka alligators developed altered gonadal and 
external genitalia morphology compared with alligators from a reference site (reviewed 
in Guillette et al., 2000; Guillette and Moore, 2006; Milnes and Guillette, 2008). These 
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results strongly suggested that developmental exposure to EDCs, transferred from mother 
to embryo via yolk, were the basis for the adverse outcomes seen in Apopka alligators: 
the decreased viability and hatching success of eggs as well as the reproductive system 
anomalies (Hamlin and Guillette, 2011).
This long-term case study coupled with the unique attributes of alligators have led 
to more than three decades of research in our laboratory utilizing the American alligator 
as a sentinel for studying environmental influences on reproductive health. Alligators are 
long-lived, and have a very high site affinity, which offers the opportunity to correlate 
reproductive health anomalies with contaminant exposure. Their semi-aquatic lifestyle 
and position as top predators also make alligators particularly susceptible to exposure 
to EDCs, many of which biomagnify across trophic levels and bioaccumulate in tissues 
(Milnes and Guillette, 2008). What really sets alligators apart as a model species, 
however, is that sex determination in the alligator is temperature dependent, rather than 
genetic (Ferguson and Joanen, 1982; Ferguson, 1985). Incubation of alligator eggs at 
30°C during a critical window known as the thermosensitive period (TSP) produces 
all females, while incubation at 33°C during the TSP produces all males (Ferguson and 
Joanen, 1982; Lang and Andrews, 1994). This makes the alligator an ideal experimental 
model for research involving sexual differentiation, and the effects of environmental 
factors such as EDCs on this process, as the sex of developing embryos can be controlled 
and manipulated in the lab via incubation temperature. 
In efforts to better understand alligator reproductive health, adult alligator FRT 
structure and function and adult reproductive endocrine physiology have been studied 
by our research group. The development of the alligator FRT has been a neglected area 
of inquiry, however. Considering the significance of FRT development in the field of 
endocrine disruption research thanks to the pivotal role the DES story played in its 
formulation, the underlying question for my dissertation research arose quite organically: 




1.2.1. Female reproductive tract development in mammals
 In the mammalian system, with XX/XY chromosomal genetic sex determination, 
the FRT pathway has long been considered to be the “default” state. During early 
development, the embryo develops a bipotential gonad and both male (Wolffian duct) and 
female (Müllerian duct, MD) reproductive tract primordia. The transcription factor Sry 
on the male Y chromosome is necessary to induce differentiation of the early bipotential 
gonad to testis, which produces anti-Müllerian hormone (AMH) and testosterone to 
induce MD degeneration and Wolffian duct (WD) promotion. In the absence of these 
male-promoting factors, the MD differentiates into the FRT, which encompasses the 
fallopian tubes, uterus, cervix and upper vagina. (reviewed in Gilbert, 2000; Kobayashi 
and Behringer, 2003; vom Saal et al., 1992; Yin and Ma, 2005)
Despite this “default” nature of mammalian FRT development, studies have 
shown that there are many important genetic factors involved in promoting regional 
differentiation of the MD (reviewed in Kobayashi and Behringer, 2003). Of interest when 
considering the potential role of estrogen signaling in FRT development is the regional 
expression of Homeobox (Hox) genes, the master regulators of axial patterning during 
embryogenesis. The chromosomal position of these genes from 3’ to 5’ corresponds 
with their anteroposterior expression along the body axis of the developing embryo 
(Krumlauf, 1994). In the developing mammalian FRT, regional expression of the Hoxa 
5’ genes correlates directly with regional differentiation. Hoxa9 is expressed in the 
developing oviduct, Hoxa10 in the uterus, Hoxa11 in the cervix and Hoxa13 in the upper 
vagina (Taylor et al., 1997). This regional expression of Hox genes is also present in 
the adult FRT and related to fertility and implantation success. Targeted disruption of 
either Hoxa10 (Satokata et al., 1995) or Hoxa11 (Hsieh-Li et al., 1995) results in female 
infertility. Experimental evidence suggests estrogen signaling is involved in regulation of 
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regional expression of Hoxa 5’ genes in the developing FRT. Developmental exposure to 
DES in mice results in a posterior shift of Hoxa9, Hoxa10 and Hoxa11 gene expression, 
accompanied by reproductive tract abnormalities indicative of a posterior shift of 
specialized FRT structures (Block et al., 2000; Ma et al., 1998). 
Whether estrogen signaling plays a role in normal mammalian FRT development 
is uncertain. Estrogens have been shown to protect the MD from degeneration induced 
by testosterone and AMH (reviewed in vom Saal et al., 1992).  In estrogen receptor 
knockout mouse models, the MD differentiates into the normal FRT regional structures, 
but the uterus is much smaller in size and unresponsive to estrogen (reviewed in Emmen 
and Korach, 2003).  It is hypothesized that the mammalian MD undergoes an estrogen-
independent “organogenetic” differentiation in early development that determines 
regional structures, and an estrogen driven “functional” differentiation at reproductive 
maturity during estrous cycles to allow for pregnancy (Kurita, 2011). 
1.2.2. Female reproductive tract development in birds
Avian sex determination is chromosomal, with a ZZ/ZW system, but in contrast 
to mammals, the female is the heterogametic sex. The actual genetic factors involved in 
gonadal sex differentiation in birds were unknown until quite recently. A Z-linked gene, 
DMRT1, is involved in testis determination in a dosage-dependent fashion, in that two 
copies, found in ZZ males, are necessary (Smith et al., 2009).  In a ZW female, the left 
gonad differentiates into an ovary, which produces estrogens that counter the effects 
of AMH, leading to oviduct development (Hamilton, 1961; reviewed in Hermansson, 
2007). In most bird species, aside from the brown kiwi and some falconiformes, only the 
left ovary and oviduct develop (Johnson, 1986). Both male and female gonads produce 
AMH, but only the left gonad in females produces estrogen to counter its effects, and 
the left MD has a higher abundance of estrogen receptors. This protects the left MD 
and promotes oviductal growth and differentiation, while the right gonad atrophies and 
6
the right MD degenerates (Hutson et al., 1985; Hutson et al., 1983; MacLaughlin et al., 
1983). It is thought that this asymmetrical female reproductive system evolved as one of 
many adaptations that make birds capable of flight (Witschi, 1935).
Estrogen appears to be a necessary factor in normal avian FRT differentiation. 
Female embryos have higher plasma estradiol than males (Woods and Brazzill, 1981), 
and administration of estrogen to male embryos results in MD retention (Willier et 
al., 1937). In ovo treatment with an aromatase inhibitor while the gonads are in a 
bipotential state results in sex reversal of genetically female chickens, with full testicular 
development and absence of both oviducts (Elbrecht and Smith, 1992).
The developing avian FRT is particularly sensitive to exogenous estrogenic input, 
and in fact there is a long history of research utilizing the developing avian oviduct as 
a test system for studying estrogen action (reviewed in Dougherty and Sanders, 2005). 
Studies in the 1930s and 1940s documented left oviductal hypertrophy and retention of 
the right oviduct when immature chickens were dosed with exogenous estrogens (Munro 
and Kosin, 1943). Further studies have shown that in ovo estrogenic stimulation induces 
cytodifferentiation and glandular morphogenesis in the avian oviduct (Andrews and Teng, 
1979; Berg et al., 2001; Kohler et al., 1969; Oka and Schimke, 1969b). 
Similarly to the DES story in humans, wild birds have suffered unintended FRT 
disruption thanks to the widespread use of the insecticide DDT for mosquito control from 
the time of WWII until its ban in 1972. Exposure to DDT and its persistent metabolite 
p,p’-DDE was directly correlated with eggshell thinning and other reproductive 
anomalies, which led to serious declines in exposed populations (reviewed in Cooke, 
1973). Adult exposure to DDT was thought to result in impaired shell formation in 
the oviduct via inhibition of carbonic anhydrase (Bitman et al., 1969), but more recent 
studies have supported the endocrine disruption paradigm of developmental exposure 
leading to adult disorders. In ovo exposure to DDT resulted in reproductive dysfunctions 
in adult chickens, including production of eggs with significantly thinner, or even absent, 
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shells (Hermansson, 2007; Holm et al., 2006). Studies in Japanese quail have also 
shown disruptions of important oviductal structures and reduced expression of calcium 
regulating factors due to in ovo exposure to DDT (Kamata et al., 2009). 
1.2.3. The alligator female reproductive tract
The adult alligator FRT is a highly regionalized tissue, in which seven 
morphologically and functionally distinct regions have been described: the anterior 
infundibulum, posterior infundibulum, tube, uterotubular junction, anterior uterus, 
posterior uterus, and vagina (Fig. 1.1). As members of the Archosaurian evolutionary 
lineage, encompassing birds, crocodilians and extinct dinosaurs, female alligators have 
a reproductive tract that shares more similarities with birds than other reptiles (Palmer 
and Guillette, 1992). In non-Archosaurian amniotes, the uterine region produces both the 
fibrous proteins that form the eggshell membrane and the outer calcareous layer of the 
eggshell, in a sequential process (Palmer, 1990). In Archosaurs, there are two spatially 
distinct regions, complete with distinct glandular structures that produce these different 
secretory products, identified here in the alligator as the anterior and posterior uterus, 
but also referred to as the “fiber region” and “calcium region” (Palmer, 1990; Palmer 
and Guillette, 1992). Thus Archosaurian eggs can be packaged in an “assembly line” 
fashion, an evolutionary adaptation that has been seen as an innovation allowing for flight 
in birds (Guillette, 1991). The major differences between crocodilians and their winged 
counterparts are that crocodilians retain paired reproductive structures, and process 
an entire clutch of eggs through their oviducts at once, while birds only retain the left 
reproductive organs and process their eggs through their oviducts one at a time (Palmer, 
1990). 
As described by Palmer and Guillette (1991), three regions of the alligator FRT 
are of particular functional importance: the tube, the anterior uterus and the posterior 
uterus. On a structural and functional level, the tubal region has a tall columnar 
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epithelium of ciliated and microvillous secretory cells and an extensive network 
of branched acinar glands that secrete glycosaminoglycans. The tube is the most 
biosynthetically active region of the reproductively active alligator FRT, and it produces 
albumen and ovotransferrin proteins (Buhi et al., 1999). The anterior uterus secretes 
protein fibers that form the eggshell membranes (Buhi et al., 1999) from branched tubular 
glands with numerous visible eosinophilic secretory granules. The posterior uterus is the 
site of the shell gland, involved in producing eggshells, and the branched tubular glands 
have fewer secretory granules than the anterior uterus, and the luminal epithelium is 
lower (Palmer and Guillette, 1992).
When reproductively active, the alligator FRT undergoes dramatic changes in 
size. A non-reproductive female two meters in total body length reportedly has oviducts 
of 45 cm in length, which can grow to be 1.5-2.5 m in length under stimulation by 
endogenous estrogen during the reproductive cycle (Guillette et al., 1997). This spike in 
estrogen signaling also induces extensive glandular development to enable the FRT to 
produce all of the secretory products necessary for proper egg packaging (Palmer, 1990).
1.2.4. Estrogens and alligator female reproductive tract development
Considering the response of the adult alligator FRT to estrogen during 
reproductive cyclicity, and the shared Archosaurian lineage between birds and alligators, 
it is probable that estrogens play a role in the developing FRT of the alligator similar to 
that in the developing avian FRT. Early studies on alligator FRT development support this 
hypothesis. In the 1930s, Thomas Forbes studied the role of steroid hormones in alligator 
reproductive system development by treating 15-month-old juvenile female alligators 
with large daily injections of estradiol benzoate (EB) over an 80 day period, resulting 
in massive oviductal hypertrophy (Forbes, 1938a; Forbes, 1938b). Over 50 years later, 
in studies on alligator MD regression, Austin (1989) noted that neonatal exposure to 
estrogen via implanted pellets also induced oviductal hypertrophy. 
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Experimental treatment with hormones in ovo has also been shown to 
influence alligator FRT development. In their in-depth investigation on the TSP of sex 
determination in alligators, Lang and Andrews (1994) showed that dosing embryonic 
alligators with estradiol-17β (E2) prior to incubation at the male producing temperature 
(MPT) during the TSP resulted in 100% gonadal sex reversal (i.e. development of ovaries 
rather than testes), and “some” oviductal hypertrophy relative to untreated animals 
incubated at the female producing temperature (FPT). Hypertrophied MDs were also 
reported following in ovo treatment with norethindrone, an aromatase inhibitor and 
synthetic progestin (Austin, 1991).  
None of these experiments documented differentiation of the MD into mature FRT 
structures on either a morphological or histological level, however.  This underscores a 
fundamental lack of knowledge on alligator FRT development, as it is unknown when the 
alligator MD normally undergoes regional differentiation. In his estrogen treatment study, 
Forbes (1938) noted that in juvenile alligators, over 1.5 years old by the end of the dosing 
regime, the oviducts of the control animals were completely undifferentiated, displaying 
the same simple columnar luminal epithelium and undifferentiated mesenchymal stroma 
observed in embryos and neonates (Forbes, 1940). While the oviducts were massively 
hypertrophied in treated females, they also lacked adult FRT characteristics; Forbes noted 
ciliation and increased height of the luminal epithelial cells and some smooth muscle 
differentiation in outer stroma, but no glandular development or distinctive regional 
characteristics (Forbes, 1938a). This matches what has been heretofore seen by our 
laboratory members in our alligator research – no differentiation of the MD or oviduct in 
alligators we have sampled at embryonic, neonatal, or juvenile stages up to 1.5 years of 
age. In mammals, the MD differentiates into the FRT structures before birth (humans) or 
not long thereafter, with full differentiation of uterine glands completed during puberty 
(Yin and Ma, 2005). The age at which alligator MD differentiates into regionalized FRT, 
and the signals involved in this process, are thus far unknown.
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1.2.5. Estrogen receptor isoforms and the induction of an unexpected alligator Müllerian 
duct phenotype 
In 2010 we conducted an experiment to investigate the effects of in ovo treatment 
with estrogen receptor (ER) isoform specific agonists on alligator sex determination. 
Exposure to exogenous estrogen can induce ovarian development in alligator embryos 
incubated at the MPT (Bull et al., 1988; Kohno and Guillette, 2013) and exposure to 
estrogenic contaminants can alter sex ratios at an intermediate temperature (Crain et al., 
1997; Milnes et al., 2005), suggesting that an estrogenic signal prior to TSP overrides 
the male-determining temperature signal. To better understand the molecular mechanism 
involved in this process, we treated embryos with pharmaceutical agents with specific 
affinities for the ER isoforms, ERα and ERβ. 
There are at least two isoforms of the ER that have been identified in all vertebrate 
classes, which have high sequence identity in their DNA binding domains but less so in 
their ligand binding domains (Katzenellenbogen et al., 2000b; Thornton, 2001). These 
structural differences are borne out in differential affinities between the two isoforms for 
exogenous ligands (Li et al., 2012). 
Studies in the red-eared slider turtle, another reptile with TSD, showed differential 
expression patterns of ERα and ERβ in the developing gonad, and differences in ovarian 
localization in response to temperature or stimulation with E2 (Ramsey and Crews, 2009). 
This led us to consider the potential roles of these ER isoforms in TSD in the alligator.  
Via receptor transactivation assays, we identified pharmaceutical agonists selective 
for the alligator ER isoforms. In ovo treatment with the ERα selective agonist propyl 
pyrazole triol (PPT) induced ovarian differentiation at the MPT, while treatment with the 
ERβ selective agonist WAY 200070 (WAY) did not (Kohno et al., 2015).
In addition to its potential role in gonadal differentiation, the interplay of signaling 
between ERα and ERβ appears to be an important regulatory mechanism in the FRT. 
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Mammalian studies suggest that estrogen-mediated cellular proliferation in the uterus 
occurs through ERα, as an ERα knockout mouse model displays decreased uterine 
growth compared to wild type (Hewitt et al., 2010). Further evidence in multiple estrogen 
signaling pathways suggest an antagonistic relationship between the ER isoforms, with 
ERβ antagonistically regulating ERα activity (reviewed in Matthews and Gustafsson, 
2003). Additionally, ER knockout mouse studies as well as studies using ER-isoform 
specific agonists in mice have shown that the FRT anomalies induced by perinatal DES 
exposure are mediated through ERα (Couse and Korach, 2004; Nakamura et al., 2008).
In our experiment, in ovo treatment with the ERα selective agonist PPT 
unexpectedly induced extreme MD enlargement. Neither treatment with E2 nor with the 
ERβ selective agonist WAY at comparable doses had this effect (Kohno et al., 2015). 
Altered MD morphology at this level had never previously been observed in our studies. 
Even when using substantially higher doses of in ovo administered E2, the only observed 
oviductal effect was increased luminal epithelial cell height (Crain et al., 1999).
This finding raised many questions around the role of estrogen signaling in 
alligator FRT development. I was intrigued that such a dramatic morphological change 
occurred due to selective agonism of one ER isoform, when many other experiments with 
endogenous and synthetic estrogens and estrogenic chemicals produced no observable 
MD effects. This PPT-induced MD phenotype initiated my dissertation project, as it 
provided a model for producing investigable alterations in developing alligator FRT 
rooted in altered endocrine signaling. 
1.3. Research goal and questions for investigation
The goal of this dissertation research is to characterize the role of estrogen 
signaling in the development of the female reproductive tract of the alligator, in 
order to provide a better understanding of how exposure to EDCs during critical 
developmental windows can disrupt this system. 
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The fortuitous discovery of the PPT-induced MD phenotype provided a jumping-
off point for further investigation. Three main questions stemming from this discovery are 
addressed in the following research chapters:
1. What are the histological and molecular characteristics of the PPT-induced MD 
phenotype, and can they be utilized to inform further exploration into the role of estrogen 
signaling in alligator FRT development?
2.  Why does only treatment with ERα selective agonist PPT, and not treatment with E2 or 
ERβ selective agonist WAY, induce these MD characteristics?
3. Do alligators from a background of contaminant exposure exhibit a different MD 
response to PPT treatment than alligators from a reference site? 
These questions are addressed in the following experiments based on utilizing the 
established model of in ovo treatment with E2 and selective pharmaceutical agonists for 
ERα and ERβ, and comparing their effects on alligator MD via histological assessment 














Fig. 1.1 The adult alligator female reproductive tract is highly regionalized.
Schematic drawing (modified from Guillette, 1992) of the adult alligator FRT external and cross 
sectional morphology. Below are representative cross sectional photomicrographs of the three 
indicated regions, tube, anterior uterus, and posterior uterus, at 4x (above) and 20x (below) 
 magnifications. Sections stained with H&E. Scale bars = 100 μm. 
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CHAPTER 2: 
In ovo treatment with an estrogen receptor alpha selective agonist causes precocious 
development of the female reproductive tract of the American alligator 
(Alligator mississippiensis)
2.1. Introduction
The American alligator has featured in multiple studies of environmental sex 
determination and the effects of environmental endocrine disruptors that have provided 
valuable insights into the lasting effects of early developmental exposures (Kohno 
and Guillette, 2013; Milnes and Guillette, 2008). Sex determination in the alligator 
is temperature dependent, rather than genetic (Ferguson, 1985), which makes it an 
interesting experimental model for research involving sexual differentiation, as the sex 
of developing embryos can be manipulated in the laboratory via incubation temperature. 
Moreover, administration of estrogens or ERα agonists to embryos incubated at the 
MPT induces ovarian development (Bull et al., 1988; Kohno et al., 2015; Kohno and 
Guillette, 2013). While multiple studies have investigated the effect of estrogens on 
ovarian differentiation in reptile species exhibiting TSD, the hormonal influences on the 
differentiation of the MD into the mature oviduct (the female reproductive tract structures 
including infundibulum, tube and uterus) remains largely unknown. In the alligator, this 
differentiation of the oviduct occurs sometime after hatching and before reproductive 
maturity, but the actual time point remains undocumented. For the purposes of this study, 
the female reproductive tract will be designated “Müllerian duct” in the embryo and 
“oviduct” after hatch out.
In birds, which share the Archosaurian evolutionary lineage with crocodilians, 
differentiation of the MD is particularly sensitive to estrogenic input.  Early studies 
documented left oviductal hypertrophy and retention of the right oviduct when immature 
chickens were dosed with exogenous estrogens (Munro and Kosin, 1943).  In the current 
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understanding of the development of the avian oviduct, genetic factors lead to ovarian 
differentiation of the left gonad, which produces estrogens that counter the effects of 
AMH, leading to oviduct development (reviewed in Hermansson, 2007). Estrogens 
are also involved in differentiation of the avian MD. In ovo estrogenic stimulation 
induces proliferation of the luminal epithelium and cytodifferentiation and glandular 
morphogenesis in the avian oviduct (Andrews and Teng, 1979; Berg et al., 2001).  
Several studies suggest that the alligator MD is similarly labile to the influence 
of estrogen signaling.  In some studies of sex determination in alligators, E2 treatment 
of eggs incubated at MPT resulted in 100% ovarian development and “some” oviductal 
hypertrophy relative to untreated animals incubated at the FPT (Bull et al., 1988; Lang 
and Andrews, 1994). Treatment of eggs incubated at FPT with a synthetic progesterone, 
norethindrone, also led to hypertrophied MDs (Austin, 1991). Postnatal estrogenic 
treatment of hatchling and juvenile female alligators up to 1.5 years of age has also been 
shown to induce oviductal hypertrophy (Austin, 1989; Forbes, 1938a; Forbes, 1938b). 
These studies support the hypothesis that the developing alligator FRT is receptive to 
estrogen stimulation and is a potential target of disruption by environmental EDCs.
The ER is highly promiscuous, having an affinity for a wide variety of compounds 
including endogenous and synthetic estrogens, plant hormones, and EDCs such as 
bisphenol A and agricultural pesticides and their metabolites (Katzenellenbogen, 
1995).  There are two isoforms of ER that have been identified in amniotes, ERα and 
ERβ, which have high sequence identity in their DNA binding domains but less so in 
their ligand binding domains (Katzenellenbogen et al., 2000a; Katzenellenbogen et al., 
2000b).  Mammalian studies of MD differentiation indicate an interplay of estrogen 
signaling between the two receptor subtypes, with ERα mediating estrogen-induced 
cellular proliferation. ERα knockout mice display decreased uterine growth linked to 
dysregulation of insulin-like growth factor-1 (IGF1) (Hewitt et al., 2010).  Similarly, ER 
knockout mice as well as studies utilizing ER-isoform selective agonists in mice have 
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shown that reproductive tract anomalies induced by exogenous estrogen exposure act 
through ERα (Couse and Korach, 2004; Nakamura et al., 2008).
Both ERs from the American alligator have been cloned and sequenced (Katsu 
et al., 2004; Katsu et al., 2010). As with other vertebrates, alligator ERs show high 
specificity for endogenous estrogens in their transactivation (Katsu et al., 2010; Kohno 
et al., 2015).  Further studies have shown that both receptor subtypes, as well as the 
androgen receptor (AR) and progesterone receptor (PGR), are expressed in oviduct of the 
juvenile alligator (Moore et al., 2012).
In a previous study, an ERα selective agonist, PPT, induced an unusual MD 
phenotype in alligator embryos incubated at the MPT (Kohno et al., 2015).  This was of 
interest for further investigation, as the embryonic development of the alligator MD is not 
well understood, and no previous studies have reported the particular MD phenotype we 
observed.  
Here we investigated the effects of in ovo stimulation of the ER subtypes with 
selective agonists in embryos incubated at the FPT to assess the effects of receptor 
subtype-specific estrogen signaling on alligator oviductal development.  We also 
examined the expression of MD genes involved in steroid hormone signaling and 
proliferation induced by estrogenic treatment in the developing female alligator.
2.2. Materials and methods
2.2.1. Egg collection, incubation and treatment
All experiments in this study involving alligators were carried out under the 
protocol approved by the Institutional Animal Care and Use Committee at the Medical 
University of South Carolina, and all fieldwork was conducted under permits from the 
Florida Fish and Wildlife Conservation Commission and the U.S. Fish and Wildlife 
Service.
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 Alligator eggs were collected from Lake Woodruff National Wildlife Refuge 
(De Leon Springs, FL, USA) under Florida Fish and Wildlife Commission permits on 
6/15/2012 and 6/21/2012.  Upon transportation to our facilities at the South Carolina 
Department of Natural Resources Marine Resources Research Institute (Charleston, SC, 
USA), eggs were weighed, candled to ascertain viability and placed in nest boxes of 
moist sphagnum moss and incubated at 30°C (FPT) in enclosed incubators. An embryo 
from each clutch was sampled and staged based on criteria from Ferguson (1985).
Once the embryos had developed to stage 19, as predicted by equation (Kohno 
and Guillette, 2013), they were randomly assigned to treatment groups: 0.5 μL/g egg 
weight (EW) absolute ethanol; 0.005, 0.05 and 0.5 μg/g EW E2 (Sigma-Aldrich, St. 
Louis, MO, USA); 0.05, 0.5, and 5 μg/g EW PPT (Tocris Bioscience, Bristol, UK); and 
0.05, 0.5 and 5 μg/g EW WAY 200070 (Tocris).  These doses were based on the doses of 
PPT and E2 that previously induced ovarian development in embryos at MPT (Kohno et 
al., 2015).  All compounds were dissolved in absolute ethanol (95% ethanol incubated for 
24 hours with molecular sieves). Eggs were weighed and treated by painting the eggshell 
surface with the appropriate dose of treatment solution (Crews and Wibbels, 1993). 
Embryos were incubated at FPT for the duration of the experiment.
Embryos were sacrificed at stage 27, which is the stage prior to hatching. At time 
of collection, eggs were re-weighed, and embryos were weighed and sacrificed. Left and 
right gonad-adrenal-mesonephros (GAM) complexes, with attached MDs, were collected 
under a dissecting microscope, the right preserved in RNAlater® (Life Technologies, 
Grand Island, NY, USA) and the left in 4% paraformaldehyde (PFA) fixative. The fixed 
tissues were incubated overnight on a shaker at 4°C. The RNAlater® -preserved tissues 
were then stored at -20°C. The PFA-fixed tissues were progressively dehydrated in 
methanol/PBST over a 24-hour period and stored in 100% methanol at -20°C.
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2.2.2. Histology
GAM tissues with attached MDs were examined for gross morphological 
characteristics under a dissecting microscope. Representative samples were photographed 
using a PixeLINK digital camera and the PixeLINK Capture OEM software (Ottowa, 
ON, Canada). 
The PFA-fixed tissues were further dehydrated through a series of isopropanol and 
xylene and paraffin infiltrated using a Leica ASP300 autoprocessor (Wetzlar, Germany), 
and embedded into paraffin using a Leica EG1150C embedder. Tissues were serially 
cross-sectioned at 7 µm using a Leica RM2255 microtome, and stained with hemotoxylin 
and eosin.  
Full serial cross sections were examined for a subset of the samples in each 
treatment group (n ≥ 5) to determine regions of interest for direct comparison. The 
anterior-posterior axis of the GAM was utilized as a metric for assessing regionalization 
of the MD. Representative digital photomicrographs were taken with a ProgRes Speed 
XT core 5 camera (Jenoptik, Jena, Germany) of a region near the anterior end of the 
GAM, and at a region just posterior of the adrenal gland, around the midpoint of the 
GAM complex. Using the IMT iSolution Lite software (Martin Microscope Company, 
Easley, SC, USA), luminal epithelial cell height was measured at four points in three 
separate sections at each of the regions examined (n = 5 samples from each treatment 
group). 
2.2.3 RNA isolation, cDNA synthesis and quantitative PCR
 RNAlater®-preserved MD tissues were manually separated from GAM 
complexes under a dissecting microscope and stored at -20°C until RNA extraction.  
Whole MDs were homogenized for RNA extraction. Methods for RNA isolation, 
cDNA synthesis and qPCR have been previously described (Kohno et al., 2015). RNA 
was isolated from tissues using the acid phenol-guanidinium thiocyanate-chloroform 
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extraction method followed by further purification using the SV Total RNA Isolation 
System with DNase-I treatment (Promega, Fitchburg, WI, USA). RNA concentration 
was measured using a Nanodrop Spectrophotometer (Thermo Scientific, Wilmington, 
DE, USA) and quality was assessed via denaturing agarose gel electrophoresis. Prior to 
cDNA synthesis, RNA was diluted to matching concentrations and used as a template 
for quantitative real-time PCR to check for genomic DNA contamination. RNA was 
reverse transcribed using the iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA) 
per manufacturer’s protocol with 15 µL RNA in 20 µL total reaction volume, and the 
resulting cDNA was diluted 1:5 in nuclease-free water.
QPCR was performed using a CFX96 real-time system (Bio-Rad). Reactions were 
performed in triplicate using 0.01 U/μl AmpliTaq Gold (Applied Biosystems, Carlsbad, 
CA, USA) and an in-house SYBR green reaction mixture consisting of 20mM Tris-
HCL (pH 7.75), 50mM KCl, 3mM MgCl2, 4% DMSO, 0.5x SYBR Green I (Thermo 
Fisher Scientific, Grand Island, NY, USA), 0.5% glycerol, 0.5% Tween 20, 0.2mM 
deoxynucleotide mix (Thermo Fisher Scientific), 0.2 µM primer mix (Eurofins Genomics, 
Huntsville, AL, USA), and 1/25 volume diluted cDNA. 
The thermal cycler program consisted of an initial denaturation step (95°C, 5 min) 
followed by 45 cycles of denaturation (95°C, 15 s) and annealing and elongation at an 
optimized temperature (45 s). After the final cycle, a dissociation curve was generated for 
each reaction to assess the reaction specificity via an incremental heating step (+0.5°C/5 s).
Primer sequences, product size and optimal annealing temperatures are listed in 
Table 1. Prior to analysis of unknown samples, the specificity of each primer pair was 
confirmed by product sequencing. Plasmid DNA standard curves of known copy number 
were generated with these sequenced products. Each 96-well plate of unknown samples 
included a standard curve, and all samples, including those of the non-template control 
and standard curve, were run in triplicate.  Mean expression values of mRNA for each 
target gene were normalized to that of ribosomal protein L8 (RPL8). Due to low mRNA 
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levels for ESR2, this gene was re-run using full concentration cDNA (not 1:5 diluted) and 
normalized to the values for RPL8 with non-diluted cDNA.
2.2.4. Statistical analysis
The effect of treatment on mean luminal epithelial cell height at both regions 
histologically examined was analyzed via one-way analysis of variance (ANOVA) 
followed by a Tukey’s multiple comparison post-hoc test. 
QPCR data were collected and analyzed using CFX Manager version 3.0 software 
(Bio-Rad).  After determining that expression of RPL8 was not significantly affected by 
treatment via one-way ANOVA, expression values of all other genes of interest were 
normalized to RPL8. Arcsine-transformed data was used to conduct one-way ANOVA 
to calculate the effect of treatment on expression of genes of interest, and outlying 
values were removed via ROUT method with a maximum false discovery rate set at 1%. 
Significance was set at p < 0.05, and a Tukey’s multiple comparison post-hoc test was 
used to detect differences among treatment groups. 
All statistical analysis was performed using both JMP12 (SAS Institute, Inc., 
Cary, NC, USA) and Graphpad Prism 6 (Graphpad Software, Inc., LaJolla, CA, USA) 
software. 
2.3. Results
2.3.1. Gross morphology of the embryonic Müllerian duct is altered by PPT treatment 
The reproductive organs of the embryonic female alligator at stage 27 include the 
paired GAM and the MDs, simple tubes that run along the distal portion of the GAM, 
connected to the GAM by the mesosalpinx, and terminate in the cloaca. Treatment with 5 
μg/g EW PPT at FPT produced enlarged MDs, thickened pubis symphysis, and enlarged 
cloaca compared to controls. As shown in Figure 2.1, compared with the vehicle control 
samples, the MDs of the high dose (5 μg/g EW) PPT-treated tissues were much larger 
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in diameter, dwarfing the GAM complex with their size and length, extending farther 
anteriorly into the abdominal cavity. While control MDs were relatively straight, simple 
tubes that ran alongside the GAM, 5 μg/g EW PPT-treated MDs were so expanded in size 
and length that they were tortuous rather than lying flush with the GAM.
Treatment with 0.5 μg/g EW PPT also induced MD enlargement, though it was 
not as extreme as the higher dose of 5 μg/g EW PPT, and the low dose PPT treatment 
(0.05 μg/g EW) did not induce any observable MD alterations (Fig. 2.1). None of the 
samples treated at any of the doses of the ERβ agonist, WAY, or the doses of E2, showed 
significant gross morphological differences from the control (Fig. 2.1).
2.3.2. PPT treatment induced glandular development in the Müllerian duct
At stage 27 the embryonic GAM and MD tissues were connected by a 
mesosalpinx and were most easily processed for histology as a complex. These GAM-
MD complexes were serially cross-sectioned and two regions along the anterior-posterior 
axis were selected for close histological examination (Fig. 2.2).  At this stage, the control 
MD was structurally simple, with a central lumen with a simple columnar luminal 
epithelium, surrounded by a fibroblastic mesenchymal stroma (Fig. 2.3).  There was a 
short region around the midpoint of the GAM complex, just posterior to the terminus 
of the adrenal gland, in which the epithelial cells lining the oviductal lumen displayed 
an increased height (Figs. 2.3B and D). This regional characteristic was displayed in all 
samples in all treatment groups examined in this study, so comparative observations were 
taken at two regions along the GAM-MD complex, as indicated in Fig. 2.2.
The histological cross sections of the medium (0.5 μg/g EW) and high dose (5 
μg/g EW) PPT-treated MDs were strikingly different from all other treatment groups, 
as was expected due to the obvious gross morphological differences (Figs. 2.4 and 2.5). 
In eight out of 11 medium dose (0.5 μg/g EW) PPT-treated tissues, the MD was greatly 
enlarged in width compared to the controls, with hypertrophied stromal cells (Fig. 2.4).  
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However, no cellular differentiation was observed in the stroma or the epithelium in 
tissues treated at this dose.
More striking characteristics were observed in the high dose (5 μg/g EW) PPT 
treatment group, which displayed not only overall MD enlargement, but also cellular 
differentiation of the stroma (Fig. 2.5).  Multiple glandular structures budded out from 
the luminal epithelium, and there was secretory material present in the lumen (Figs. 
2.5A and C). Proceeding posteriorly along the oviduct, these glandular structures were 
less numerous and there was a greater proportion of connective tissue in the stroma 
(Figs. 2.5B and D). None of the other treatment groups, including the 0.5 μg/g EW PPT 
treatment group, developed any of these differentiated structures. 
2.3.3. PPT treatment induces increased luminal epithelial cell height in the embryonic 
alligator Müllerian duct.
The MD luminal epithelium was also altered by PPT treatment. The epithelium of 
the MD at stage 27 in the controls was simple columnar (Figs. 2.3A and C), with a region 
of greater proliferation and increased cell height near the middle of the GAM complex 
(Figs. 2.3B and D). The epithelial cell heights at both the anterior and middle region of 
the 5 μg/g EW PPT-treated MDs were significantly higher than all other treatment groups 
(p <0.0001, Fig. 6). The high dose (5 μg/g EW) PPT-treated luminal epithelial cells are 
also ciliated, a characteristic that none of the other treatment groups displayed (Figs. 2.5C 
and D). 
2.3.4. PPT treatment alters gene expression in the embryonic Müllerian duct
ERα mRNA expression in MD was reduced nearly threefold by 5 μg/g EW PPT 
treatment (Fig. 2.7).  ERβ and PGR mRNA levels were very low in embryonic MD of 
controls, but PPT treatment significantly increased them at both the medium (0.5 μg/g 
EW) and high dose (5 μg/g EW) levels (Fig. 2.7).  PGR mRNA was 12-fold higher at the 
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medium dose and 25-fold higher at the high dose of PPT-treatment than controls (Fig. 
2.7).  AR expression in MD was increased threefold by 5 μg/g EW PPT treatment (Fig. 
2.7).  IGF1 expression in MD was increased five-fold at both 0.5 μg/g EW and 5 μg/g 
EW PPT doses (Fig. 2.7).  
 Expression of IGF1 receptor (IGFR), epidermal growth factor (EGF), EGF 
receptor (EGFR) and proliferating cell nuclear antigen (PCNA) were not significantly 
altered by the treatments (Fig. 2.8).
2.4. Discussion
The MD phenotype induced by in ovo treatment with 5 μg/g EW PPT was 
substantially different from controls and all other treatments in this experiment. The 
histological characteristics of these high-dose PPT-treated MD are more similar in 
appearance to the vitellogenic adult alligator oviduct than to what has been previously 
observed and documented in normal stage 27 alligators incubated at FPT. The mature 
alligator oviduct is differentiated into highly specific regions with distinct characteristics 
and functions. Three regions are of particular importance: the tube, the anterior uterus 
and the posterior uterus. The tubal region has a tall columnar epithelium of ciliated and 
microvillous secretory cells and an extensive network of branched acinar glands that 
secrete glycosaminoglycans (Bagwill et al., 2009; Palmer and Guillette, 1992). The 
anterior uterus secretes protein fibers from branched tubular glands with numerous visible 
eosinophilic secretory granules, while the posterior uterus is the site of the shell gland, 
and the branched tubular glands have fewer secretory granules than the anterior uterus. 
Progressing posteriorly along the oviduct, stromal glands become less pronounced and 
there is a greater area of connective tissue, surrounded by layers of smooth muscle. 
(Bagwill et al., 2009; Palmer and Guillette, 1992).
While not directly congruent with the adult oviduct, the MDs of the embryonic 
alligators treated with 5 μg/g EW of PPT in this study display similar regional 
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characteristics. A higher proportion of glands fill the stroma at the anterior end, and these 
glands become less prominent moving posteriorly along the tissue. Connective tissue 
becomes more obvious in the posterior regions of the MD, and the outer portion appears 
to be differentiating into smooth muscle.
While previous studies have shown oviductal hypertrophy following treatment 
with estrogens, no studies document glandular differentiation in the immature alligator 
oviduct or embryonic MD. Forbes (1938b) noted smooth muscle differentiation in the 
outer stroma in the hypertrophied oviducts of 15-month-old alligators injected 3 or more 
times a week for 80 days with large doses of EB. This smooth muscular differentiation 
increased posteriorly, similarly to the regionalized characteristics in adult oviducts 
(Bagwill et al., 2009; Palmer and Guillette, 1992) and in the 5 μg/g EW PPT-treated 
MDs in this study. There is only one study in the literature that documents histological 
characteristics of hypertrophied oviducts induced by in ovo treatment, in this case with 
the synthetic progestin norethindrone (Austin, 1991). Serial cross sections reportedly 
showed no regional differences, and the sections adjacent to the end of the adrenal gland 
selected for close examination (likely the same area as the mid-GAM sections examined 
in our study) showed stromal expansion with no glandular or muscular differentiation 
(Austin, 1991). In our studies involving in ovo administration of estrogens and other 
endocrine-active compounds to alligators, we have not previously observed precocious 
differentiation of the oviduct. Even when using substantially higher doses of in ovo 
administered E2, the only observed oviductal effect was increased luminal epithelial cell 
height (Crain et al., 1999). To our knowledge, only treatment with the ERα selective 
agonist PPT has induced the phenotype of precocious glandular differentiation in the 
alligator MD or immature oviduct. 
There are several possible modes of action for why PPT and not any other 
ER ligands have had this effect on the alligator MD. Considering that PPT is a 
pharmaceutical agent, it is possible that its effect is related to its metabolism. All of the 
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treatments in this study were administered in a single dose at stage 19. The half-life of 
PPT administered to an embryonic alligator via the eggshell surface is unknown, so it 
may remain in circulation much longer than E2 and other treatments, causing prolonged 
stimulation. The elimination half-time in serum for PPT administered subcutaneously in 
adult ovariectomized rats is six hours (Sepehr et al., 2012). We analyzed PPT-induced 
effects at stage 27, approximately 38 days after treatment. Thus, the effects of PPT in 
this study are not likely to be due to prolonged stimulation. Further investigation into the 
pharmacokinetics of PPT in ovo is needed.
 While PPT was developed as a selective ERα agonist and was tested specifically 
on the alligator ERα via transactivation assay (Kohno et al., 2015), it is possible that 
it may have off-target effects on other steroid hormone receptors. As previously noted, 
in ovo treatment with a synthetic progestin induced oviductal hypertrophy (Austin, 
1991), so it is possible that PPT may have affinity for the PGR. Expression of PGR was 
significantly increased by both 0.5 μg/g EW and 5 μg/g EW PPT treatment in our study. 
However, in the chicken embryo, oviductal expression of PGR increases upon estrogen 
stimulation and administration of progesterone inhibits estrogen-induced glandular 
differentiation in the embryonic chicken oviduct (Dougherty and Sanders, 2005; Oka and 
Schimke, 1969a, b; Palmiter and Wrenn, 1971). This strongly suggests an antagonistic 
role for progesterone in regulating estrogen stimulation in the developing avian oviduct. 
The developing alligator oviduct may be similarly regulated; further investigations are 
required to test this hypothesis.  
We also investigated the expression of growth factors known to be involved in 
estrogen-induced proliferation in the FRT, EGF and IGF-1 (DiAugustine et al., 1988; 
Murphy et al., 1987), and their respective receptors. While there were no differences in 
EGF expression among the treatment groups, both 0.5 μg/g EW and 5 μg/g EW PPT 
treatment induced a significant increase in IGF1 expression. The PPT-induced increase 
in IGF1 and not EGF may be due to the more central role of IGF-1 in the proliferation of 
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the avian and reptilian oviduct. In the avian oviduct, oviductal IGF1 expression increases 
in direct correlation with increasing oviductal size in immature Japanese quail (Fu et al., 
2001) and it increases robustly following DES injection (Kida et al., 1994). Similarly, 
in reptiles, administration of IGF-1 via slow-release pellet induced a greater degree of 
oviductal proliferation in ovariectomized geckos than EGF (Cox, 1994). IGF-1 is known 
to be increased in the vitellogenic adult alligator oviduct (Cox and Guillette, 1993), so 
it is probable that IGF-1 is the primary mitogen involved in estrogen-induced oviductal 
proliferation in the alligator.
 Taken all together, these results strongly suggest that the observed effect of 
PPT on the developing alligator oviduct is in fact due to its selective stimulation of 
ERα. Studies of the role of estrogens in the development of the FRT in mammals and 
birds show that the proliferative and differentiative effects of estrogen are mediated 
through ERα. In ovo exposure to DES results in rapid stromal hypertrophy and glandular 
formation in the chicken oviduct (Kohler et al., 1969), and the effects of DES have been 
shown to be mediated through ERα in the mammalian FRT (Couse and Korach, 2004; 
Nakamura et al., 2008). Moreover, in ovo exposure to PPT results in disrupted oviductal 
differentiation in female chickens, including hypertrophy and retention of the right 
oviduct, and partial oviductal development in males (Mattsson, 2008; Mattsson et al., 
2011). Thus, estrogens play an important role in the normal differentiation of the avian 
FRT, but selective stimulation of ERα results in disrupted development. Murine studies 
of estrogen-regulated pathways suggest an antagonistic relationship between the estrogen 
receptor subtypes, with ERβ antagonizing ERα activity (Matthews and Gustafsson, 
2003). PPT treatment seems to result in excess stimulation of oviductal proliferation, 
without ERβ signaling pathways to keep it in check.
 In conclusion, stimulation of ERα in ovo at FPT induced significant enlargement 
of the alligator MD with precocious development of secretory glands and connective 
tissue differentiation similar to characteristics of mature adult oviduct. Increased 
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expression of ERβ, progesterone receptor, androgen receptor and insulin-like growth 
factor 1 might explain the phenomena in the MD.  These results suggest that the 
embryonic alligator MD is labile to exogenous estrogen signaling through ERα, and 
ligands that selectively agonize ERα can disrupt normal FRT development.
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Table 1. Primers for quantitative real-time PCR  
Primer 








ACTβ GAGGGTTTTAGGTGTAACTGCTTG 195 65 NM_001286847.1, GCA_000281125.1* ACATACTGGCACCGCTTTTC 
AR 
GCCAGACTCCTTCTCCAACC 
177 62 LC012894.1 
TCTCCATCCCATGGCGAAAA 
EEF1 CGTTCTGGTAAGAAGCTGGA 169 62 XM_006269752.2 TGACACCAACAGCAACAGTC 
EGF 
GACCTGGTTTGGCCTAGTGG 
































115 62 XM_006266675.2 
GTTTGTCAATACGACCTCCAC 
	
* primer set designed using alignment of A. sinensis sequence with A. mississippiensis 
genome (St John et al., 2012) 
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Fig. 2.1.  Gross morphology of embryonic alligator GAM complex and Müllerian duct at stage 27.
Stage 27 alligator GAM and MD treated with (A) 0.5 μL/g EW EtOH (vehicle control); (B) 0.005 
μg/g EW E₂; (C) 0.05 μg/g EW E₂; (D) 0.5 μg/g EW E₂; (E) 0.05 μg/g EW WAY; (F) 0.5 μg/g 
EW WAY; (G) 5 μg/g EW WAY; (H) 0.05 μg/g EW PPT; (I) 0.5 μg/g EW PPT; and (J) 5 μg/g EW 
PPT.  All scale bars indicate 3 mm.  All tissues shown in lateral view; tissue orientation in (A) 
 indicated by the terms anterior, posterior and ventral is consistent in all other images. Arrow 






Fig. 2.2.  Schematic of embryonic alligator GAM and Müllerian duct at stage 27.
Dorsal view of the average stage 27 alligator GAM and Müllerian duct indicating where cross sections 
were observed. (Modified from Deeming et al., 1988). Dashed lines indicate where along the 
anterior-posterior axis cross sections were examined for histological analysis.  A, adrenal gland; G, 
gonad; M, mesonephros; Md, Mülllerian duct.
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Fig. 2.3.  Histology of Müllerian duct and GAM complex at stage 27 in controls.
Representative cross sections of Müllerian duct and GAM complex at stage 27 on the anterior 
plane (A) and the posterior plane (B) as shown in Fig. 2.  Boxed MDs in A and B are shown with 
higher magnification in C and D.  The egg at FPT was treated with 0.5 μL/g EW EtOH (vehicle 
control) at stage 19.  A, adrenal gland; G, gonad; M, mesonephros.  Scale bars indicate 100 μm.
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Fig. 2.4.  Histology of Müllerian duct and GAM complex at stage 27 in medium-dose PPT-treated group.
 Representative cross sections of Müllerian duct and GAM complex at stage 27 on the anterior 
plane (A) and the posterior plane (B) as shown in Fig. 2.2.  Boxed MDs in A and B are shown 
with higher magnification in C and D.  The egg at FPT was treated with 0.5 μg/g EW PPT in 
EtOH at stage 19.  A, adrenal gland; G, gonad; M, mesonephros.  Scale bars indicate 100 μm.
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Fig. 2.5.  Histology of Müllerian duct and GAM complex at stage 27 in high dose PPT-treated group.
Representative cross sections of MD and GAM complex at stage 27 on the anterior plane (A) and 
the posterior plane (B) as shown in Fig. 2.2.  Boxed portions of MDs in A and B are shown with 
higher magnification in C and D.  The egg at FPT was treated with 5.0 μg/g EW PPT in EtOH at 
stage 19.  A, adrenal gland; G, gonad; M, mesonephros.  Scale bars indicate 100 μm.
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Fig. 2.6.  Luminal epithelial cell heights in the stage 27 embryonic alligator oviduct.
Mean cell heights of the MD simple columnar luminal epithelium across the treatment groups for 
the anterior cross sectional plane (left) and the more posterior cross sectional plane (right).  Triangles 
under bars indicate treatment dose, low to high. Error bars indicate standard error of mean.  p-values 
given for one-way ANOVA. Letters above columns indicate significantly different groups by 
Tukey’s post-hoc test.
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Fig. 2.7.  Expression of steroid hormone receptors and IGF-1 in alligator Müllerian duct at embryonic stage 27.
Expression values reported as relative expression normalized to ribosomal protein L8 (RPL8).  
Triangles under bars indicate treatment dose, low to high.  Error bars indicate standard error mean.  
p-values based on one-way ANOVA.  Letters above bars indicate significantly different groups based 
on Tukey’s posthoc test.
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Fig. 2.8. Expression of growth factors and proliferation marker in alligator Müllerian duct at stage 27.
Expression values reported as relative expression normalized to RPL8. Triangles under bars 




Investigations into the contrasting effects of treatment with estradiol-17β and 
estrogen receptor selective agonists on the development of the alligator Müllerian 
duct: ligand persistence and unbalanced receptor isoform signaling
3.1. Introduction
We have previously reported that in ovo treatment with the ERα-selective agonist 
PPT induced a phenotype of precocious development in the embryonic alligator MD (ch. 
2 and Doheny et al., 2016). Estrogen-induced cytodifferentiation and glandulogenesis is 
well-studied in the developing avian FRT (Dougherty and Sanders, 2005; Kohler et al., 
1969). Based on their shared Archosaurian lineage and similar adult FRT characteristics 
(Palmer and Guillette, 1992), it is a reasonable assumption that the process of 
differentiation of MD to FRT in alligators and birds should be similar. However, estrogen-
induced glandulogenesis had not previously been documented in the alligator MD. 
Our studies are the first to show that this phenotype can only be induced with an ERα 
selective agonist. 
 The processes of cytodifferentiation in the developing FRT of the alligator have 
not been previously investigated, neither following treatment with exogenous hormonally 
active compounds nor under normal conditions. The timepoint at which the alligator MD 
differentiates from a uniform structure to the regionalized structures of the mature FRT 
under normal conditions is not yet reported; it must occur at some point later than 1.5 
years of age, after it becomes logistically difficult to maintain alligators in the laboratory. 
In contrast, the FRT is regionally differentiated at birth or not long thereafter in mammals 
(Yin and Ma, 2005) and birds (Dougherty and Sanders, 2005). Embryonic PPT treatment 
offers a model for investigating these processes in the alligator MD. We have shown that 
when PPT treatment is administered prior to the TSP, the alligator MD has developed 
glandular structures in a regionalized pattern by stage 27, just prior to hatchout. 
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Investigation of MD characteristics at several stages post-treatment could offer insight 
into the processes involved in this cytodifferentiation.
We have hypothesized that the effects of PPT on alligator MD are likely due 
to its selective activation of ERα over ERβ. Studies of estrogen receptor isoform-
specific knockout mouse models suggest that ERα is necessary for proliferation and 
differentiation of the uterus, while ERβ plays a regulatory role, attenuating the effects 
of ERα (Weihua, Saji et al. 2000; Matthews and Gustafsson 2003). In our research, the 
differentiated alligator MD phenotype has only occurred with PPT treatment and not with 
E2 treatment or treatment with ERβ selective agonist WAY, suggesting that the receptor 
isoforms may have similar roles in alligator FRT as in mammals. PPT treatment induced 
proliferation and differentiation in alligator MD, while activation of both receptors via 
treatment with the exogenous ligand, E2, did not. Half maximal effective concentration 
(EC50) values measured in receptor transactivation assays showed that E2 is more 
selective for ERα than ERβ, but PPT exhibits negligible activation of ERβ (Kohno et al., 
2015). Therefore, we suggest that the difference in MD phenotype following treatment 
with E2 versus PPT is due to an imbalance in signaling through the ER isoforms, with 
PPT activating ERα in the absence of ERβ.
However, there is a second hypothesis for the differential effects of PPT and 
E2 on alligator MD: that the pharmaceutical agonist PPT has a longer half-life than the 
native ligand. Our experiments utilized single dose administration, so a difference in 
metabolism of the treatment compounds could result in a difference in the duration of 
receptor activation. The half-life of estradiol 17-β is less than 24 hours (12-17 hours in 
humans) (Norris, 1997). As previously addressed in ch. 2, the half-life of PPT in adult 
ovariectomized rats is six hours (Sepehr et al., 2012), but the actual pharmacokinetics 
of this compound administered to alligator embryos via eggshell surface painting is 
unknown and beyond the scope of this investigation. Xenobiotic metabolism is not 
well-studied in wildlife in general, but it is known to often vary greatly from what 
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is seen in model organisms, as it is influenced by multiple factors such as body size, 
thermoregulation and dietary makeup (Hutchinson et al., 2014).
 The goal of the following experiments was to investigate more deeply the 
mechanism of PPT-induced MD differentiation. We first compared the effects of PPT 
treatment and E2 treatment on the alligator MD to normal male and female temperature 
development at four embryonic developmental stages, to better characterize the process 
of PPT-induced cytodifferentiation.
We tested the half-life hypothesis by comparing the effects of in ovo E2 and PPT 
treatment on alligator MD with those of estradiol benzoate (EB), an estrogen ester. While 
pharmacokinetics of EB in alligator embryos are unknown, clinical studies in humans 
have shown that estrogen esters have a longer half-life than E2 but similar receptor 
kinetics (Oriowo et al., 1980).
If an imbalance in receptor isoform signaling is a contributing factor in the PPT-
induced MD phenotype, we hypothesized that treating with selective agonists for both 
ERα and ERβ should have a “rescue” effect on alligator MD, producing a phenotype 
similar to vehicle-treated controls or to that produced by E2 stimulation. We thus 
compared the effects of PPT, E2, WAY, and two combinatorial treatments of PPT and 
WAY on alligator MD. 
3.2. Materials and methods
3.2.1. Egg collection and incubation
All experiments in this study involving alligators were carried out under the 
protocol approved by the Institutional Animal Care and Use Committee at the Medical 
University of South Carolina. Alligator eggs were collected from Lake Woodruff National 
Wildlife Refuge under Florida Fish and Wildlife Commission permits on 6/22/2011 and 
on 6/20/2013. Upon transportation to our facilities at the South Carolina Department of 
Natural Resources Marine Resources Research Institute, eggs were weighed, candled to 
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ascertain viability and placed in nest boxes of moist sphagnum moss and incubated at 
30°C (FPT) in enclosed incubators. An embryo from each clutch was sampled and staged 
based on criteria from Ferguson (1985).
3.2.2. Treatment and tissue collection
The designs for the experiments detailed in this chapter are graphically depicted 
in Fig. 3.1. For the first experiment, conducted on eggs collected in 2011, once the 
embryos had developed to stage 19, they were randomly assigned to treatment groups: 
0.5 µL/g EW ethanol, 0.5 µg/g EW E2 (Sigma-Aldrich, St. Louis, MO, USA), or 5 µg/g 
EW PPT (Tocris Bioscience, Bristol, UK), doses based on previous experiments. Stock 
treatment solutions were prepared by dissolving compounds in absolute ethanol (95% 
ethanol incubated for 24 hours with molecular sieves). Eggs were weighed and treated by 
painting the surface with the appropriate dose of treatment solution. Embryos assigned to 
the FPT control group were returned to 30°C incubation, but all other treatment groups 
were transferred to incubation at the MPT, 33°C. 
Embryos were randomly assigned to be collected at developmental stages 
21, 23, 25 and 27. When the appropriate time point arrived for collection, based on 
a developmental equation (Kohno and Guillette, 2013), eggs were re-weighed, and 
embryos were weighed and sacrificed. GAM complexes, with attached MDs, were 
collected, one placed in RNAlater® (Life Technologies, Grand Island, NY, USA) and 
one in Bouin’s fixative, alternating between samples to randomize which side was used 
for which analysis type. The fixed tissues were incubated for 24 hours on a shaker at 4°C. 
The RNAlater® -preserved tissues were then stored at -20°C. The Bouin’s-fixed tissues 
were transferred to lithium-saturated 70% ethanol and stored at 4°C.
For the second experiment, conducted on eggs collected in 2013, embryos were 
incubated in the laboratory until stage 19, and then assigned randomly into treatment 
groups: 0.5 µL/g EW EtOH, 0.5 µg/g EW E2, 0.5 µg/g EW EB (Sigma-Aldrich, St. 
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Louis, MO, USA), 5 µg/g EW WAY, 0.5 µg/g EW PPT, 5 µg/g EW PPT, or combinatorial 
treatments of PPT and WAY, 0.5 µg/g EW PPT + 5 µg/g EW WAY and 5 µg/g EW PPT 
+ 5 µg/g EW WAY (see Fig. 3.1 for design schematic). Treatments were prepared and 
applied as described above, and all eggs were incubated at FPT for the duration of the 
experiment. 
All embryos were sacrificed at stage 27 and GAM/MD complexes collected 
as described above, the right preserved in RNAlater® and the left in 4% PFA. After 
overnight incubation at 4°C on a shaker, the RNAlater®-preserved tissues were then 
stored at -20°C. The PFA-fixed tissues were progressively dehydrated in methanol/PBST 
over a 24-hour period and stored in 100% methanol at -20°C.
3.2.3. Histology
Preserved tissues were examined under a dissecting microscope and photographed 
using a PixeLINK digital camera and the PixeLINK Capture OEM software. 
GAM/MD complexes were dehydrated through graded isopropanol and paraffin 
infiltrated using a Leica ASP300 autoprocessor, and paraffin embedded using a Leica 
EG1150C embedder. 2011 tissues were serially cross-sectioned at 7 µm using a Leica 
RM2255 microtome. Slides were stained using a modified Masson trichrome stain 
(Humason, 1979). Serial cross sections from  5 samples per treatment per stage were 
examined for morphological characteristics. A subset of slides from stage 27 were 
stained using a combination McMannus’ Periodic Acid Schiff’s (PAS)/ Alcian blue 
(AB) technique with pH 2.5 AB (Bancroft and Gamble, 2008) to examine histochemical 
profiles.  
The 2013 samples were serially cross-sectioned or serially lateral-sectioned at 
8 µm using a Leica manual rotary microtome, and stained with hemotoxylin and eosin 
using a Leica Autostainer XL with a Leica CV5030 coverslipper.
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For each treatment group, five samples were examined in full, 2-3 as serial cross 
sections and 2-3 as serial lateral sections.
Representative digital photomicrographs were taken with a ProgRes Speed XT 
core 5 camera (Jenoptik, Jena, Germany).
3.2.4. Sexing of embryos
At stages 25 and 27, the embryos were sexed based on gonadal characteristics, 
as described by Smith and Joss (1993). Stage 21 and 23 gonads were too ambiguous for 
definitive sexing. Two stage 27 MPT- incubated vehicle control embryos were classified 
as female based on gonadal characteristics, so they were removed from all further 
analysis to not skew results. 
3.2.5. RNA isolation, reverse transcription and quantitative PCR
 For the 2011 samples, RNA isolation and reverse transcription and QPCR were 
performed according to methods detailed in chapter 2. RNAlater® -preserved MD 
tissues were manually separated from GAM complexes under a dissecting microscope 
and stored at -20°C until RNA extraction. For three of the stage 27 vehicle control 
MPT samples, MD was fully or partially regressed, so these samples were omitted from 
further analysis.  Whole MDs were homogenized and RNA isolated from tissues using 
the acid phenol-guanidinium thiocyanate-chloroform extraction method followed by 
further purification using the SV Total RNA Isolation System with DNase-I treatment 
(Promega, Fitchburg, WI, USA). RNA concentration was measured using a Nanodrop 
Spectrophotometer (Thermo Scientific, Wilmington, DE, USA) and quality was assessed 
via denaturing agarose gel electrophoresis. Prior to cDNA synthesis, RNA was diluted to 
matching concentrations and used as a template for quantitative real-time PCR to check 
for genomic DNA contamination. RNA was reverse transcribed using the iScript cDNA 
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Synthesis kit (Bio-Rad, Hercules, CA, USA) per manufacturer’s protocol with 15 μL 
diluted RNA in 20 μL total reaction volume, and the resulting cDNA was diluted 1:5 in 
nuclease-free water.
 This protocol was slightly modified for the 2013 samples. Whole MDs (n=8 per 
treatment group) were homogenized for RNA extraction via the SV Total RNA Isolation 
System with DNase-I treatment (Promega). RNA concentration and quality was assessed 
as described, then RNA was diluted to matching concentrations. Reverse transcription 
was performed using the High-Capacity cDNA Reverse Transcription Kit with RNase 
Inhibitor (Applied Biosystems, Foster City, CA, USA) per manufacturer’s protocol, using 
10 μL diluted RNA in 20 μL total reaction volume, and the resulting cDNA was diluted 
1:5 in nuclease-free water.
QPCR was performed using a CFX96 real-time system (Bio-Rad). Reactions were 
performed in triplicate using 0.01 U/μl AmpliTaq Gold (Applied Biosystems, Carlsbad, 
CA, USA) and an in-house SYBR green reaction mixture described in chapter 2, and 1/25 
volume diluted cDNA. The thermal cycler program consisted of an initial denaturation 
step (95°C, 5 min) followed by 45 cycles of denaturation (95°C, 15 s) and annealing 
and elongation at an optimized temperature (45 s). After the final cycle, a dissociation 
curve was generated for each reaction to assess the reaction specificity via an incremental 
heating step (+0.5°C/5 s).
Primer sequences, product size and optimal annealing temperatures are listed in 
Table 1 (pg. 28). Primer specificity was assessed as described in chapter 2. 
3.2.6. Statistical analysis
QPCR data were collected and analyzed using CFX Manager version 3.0 
software.  For the 2011 samples, three internal control genes, EEF1, ACTB, and 
RPL8, were assessed, but no single internal control gene was appropriate for use as a 
normalization factor, as all three showed significant effects of treatment via one-way 
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ANOVA. For normalization of QPCR values, a normalization factor (NF2) was calculated 
based on the geometric mean of all three internal control genes using the geNORM 
analytical tool (Vandesompele et al., 2002). Absolute copy number of each target gene 
was divided by NF2 and reported as relative expression. These normalized expression 
values were used to conduct one-way ANOVA to calculate the effect of treatment on 
target genes at each of the four developmental stages, and outlying values were removed 
via ROUT method with a maximum false discovery rate set at 1%. Significance was set at 
p < 0.05, and a Tukey’s multiple comparison post-hoc test was used to detect differences 
among treatment groups. 
For the 2013 sample set, expression of ACTB was not significantly affected by 
treatment via one-way ANOVA, so expression values of all other genes of interest were 
normalized to ACTB. Data were log-transformed to achieve homogeneity of variance. 
One-way ANOVA was utilized to calculate the effects of treatment on expression levles 
of genes of interest. Outlying values were removed by examination of a residual plot and 
ROUT method with a maximum false discovery rate set at 1%. Significance was set at p 
< 0.05, and a Tukey’s multiple comparison post-hoc test was used to detect differences 
among treatment groups. 
All statistical analysis was performed using both JMP12 and Graphpad Prism 6 
software. 
3.3. Results
3.3.1. Treatment effects on morphological characteristics of Müllerian duct 
 As seen previously (Kohno et al., 2015), PPT treatment at MPT induced 
significant MD enlargement, while E2 treatment did not. This enlargement was already 
apparent at stage 23 and became increasingly more pronounced at later stages (Fig. 3.2). 
At stage 27 in the MPT vehicle control samples, complete MD regression was observed 
in two samples, and partial MD regression in 5 samples.
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For the 2013 samples, the morphological characteristics of MD of the vehicle 
control samples and those treated with 0.5 µg/g EW E2, 5 µg/g EW WAY, and the 0.5 
µg/g EW and 5 µg/g EW doses of PPT at FPT were identical to what has previously 
been documented for these treatments in chapter 2. There were no observable gross 
morphological differences between MD treated with E2 or EB. 
Contrary to our hypothesis, the co-treatment with WAY did not alter the PPT-
induced MD phenotype. The combined 0.5 µg/g EW PPT + 5 µg/g EW WAY treated 
MDs were similar to those treated with 0.5 µg/g EW PPT, somewhat enlarged compared 
to the controls. The combined 5 µg/g EW PPT + 5 µg/g EW WAY treated MDs were 
similar to the 5 µg/g EW PPT treated MDs, massively hypertrophied compared to the 
controls. The hypertrophied MDs from these treatment groups were weighed prior to 
RNA extraction for proper calculation of reagents, and there was no difference in mean 
MD mass (5 µg/g EW PPT mean = 51.38  7.84 mg, 5 µg/g EW PPT + 5 µg/g EW WAY 
mean = 43.25  6.05 mg, two-tailed t-test p = 0.43).
3.3.2. Histological characteristics of the gonads and determination of sex
For the 2011 samples, gonadal morphology was examined at stages 25 and 27 to 
sex embryos. At stages 21 and 23, gonadal morphology was too ambiguous to determine 
sex. The defining characteristics for identifying testis differentiation in alligator are 
well-defined medullary sex cords with enlarged cells, and the defining characteristics for 
ovarian differentiation are lacunae in the medulla and a well-defined cortex with germ 
cells (Smith and Joss, 1993). Treatment with E2 and PPT induced ovarian formation 
at MPT in all stage 25 and stage 27 embryos. E2-treated gonads were morphologically 
similar to those of the FPT vehicle control samples, but PPT-treated gonads showed 
structural differences, with larger lacunae and less cortical definition than controls and 
E2-treated gonads (Fig. 3.3).
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As described in the methods section, all but two of the MPT stage 25 and stage 
27 vehicle control gonadal samples showed well-defined sex cords, the main testicular 
characteristic identifiable at these stages (Fig. 3.3). These stage 27 MPT control samples 
with ovaries were removed from further analysis. This and other incidences of females 
occurring despite incubation at MPT throughout the canonical TSP inspired a study 
in our research group that determined the window of thermosensitivity in alligators 
is longer than previously documented (McCoy et al., 2015). The feminized males in 
this study were from a clutch collected from the field at an earlier developmental stage 
and thus held longer at the FPT than others, which likely influenced their gonadal sex 
determination in a female direction.  
3.3.3. Treatment effects on Müllerian duct histology
For the 2011 samples, MD structure was similar for FPT control samples and 
MPT E2-treated samples across all the stages examined, displaying the simple columnar 
luminal epithelium and fibroblastic mesenchymal stroma previously characterized in 
chapter 2. 
 At stage 21, the MPT PPT-treated samples were not distinctly different 
histologically from the FPT controls, aside from enlarged size due to some stromal 
expansion (Fig. 3.4). By stage 23, this stromal expansion in the MPT PPT-treated MDs 
was much more apparent and involved hypertrophy of the stromal cells due to imbibition 
(Fig. 3.4). At stage 25, there was glandular formation along the luminal epithelium of 
these MPT PPT-treated MDs (Fig. 3.4). 
The stage 27 MPT PPT-treated tissues displayed the same characteristics 
documented in ch 2. With the use of modified trichrome stain, the formation of 
connective and muscular tissues in the periphery of the stroma was evident, as connective 
tissue stains green and muscular tissue red (Fig. 3.4). At stage 27 in the MPT control 
47
samples, complete MD regression was observed in two samples and partial MD 
regression in 5 samples. 
As with the FPT samples characterized in ch. 2, stage 27 MPT PPT-treated MD 
in this experiment showed anterior-posterior regionality. The epithelium of more anterior 
regions of the MD was expanded with glands (Fig. 3.5A), while more posterior regions 
had fewer glands and more connective tissue and smooth muscle differentiation (Fig. 3.5 
B). These regions also stained differently with AB/PAS. In the more anterior region, the 
luminal epithelium is positive for AB, while the glands are PAS positive (Figs. 3.5 C and 
3.5 E), and in the more posterior region, the staining was less intense in general but the 
epithelium was positive for both AB and PAS, while the glands were only AB positive 
(Figs. 3.5 D and 3.5 F).  
In the 2013 samples, as seen with morphological characteristics, the histological 
characteristics of previously examined treatments recapitulated what has been previously 
described in chapter 2. The EB-treated MD displayed similar characteristics to the E2-
treated and control tissues. There were no observable histological differences between 0.5 
μg/g EW PPT-treated MD and the MDs treated with combined 0.5 μg/g EW PPT + WAY, 
and no observable differences between the 5 μg/g EW PPT-treated MDs and combined 5 
μg/g EW PPT + WAY samples.
Lateral sectioning of a subset of samples confirmed previous observations on 
anterior-posterior regional differences in the stage 27 alligator MD treated with 5 μg/g 
EW PPT at FPT (Fig. 3.6).  At the anterior end, the stroma of the enlarged MD was 
densely packed with secretory glands. Moving posteriorly, there were fewer glands and 
the stroma was made up of irregular cells and loose connective tissue. 
3.3.4. Treatment effects on expression of key genes in Müllerian duct 
 In the 2011 sample set, at MPT, PPT affected expression of key genes in MD at 
all stages sampled. For the steroid hormone receptors (SHRs) analyzed, overall, PPT 
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treatment resulted in decreased expression of ESR1 and increased expression of ESR2, 
PGR, and AR (Fig. 3.7). At stage 21, ESR1 expression was significantly reduced in PPT-
treated MD compared to FPT controls, but not compared to E2-treated MD. At stages 23 
and 25, however, ESR1 expression was similar in MPT and FPT controls and E2-treated 
MD, while it was significantly decreased in PPT-treated MD. At stage 27, this trend was 
not quite as extreme, but ESR1 expression was still significantly lower in PPT-treated 
tissues than in FPT controls. 
 ESR2 expression was very low in MD across all stages and treatments, and at 
stage 21 there were no significant differences in expression among the treatments. In 
MPT PPT-treated MD, ESR2 expression increased over the developmental time course, 
and was significantly higher than FPT controls at stages 23, 25 and 27.  PGR expression 
was significantly higher in PPT-treated MD than all other treatments at every stage 
sampled. Expression of AR was significantly higher in PPT-treated tissues than all other 
treatments at stages 21, 23 and 25, but at stage 27 AR expression in PPT-treated MD 
decreased to a level similar to E2-treated and MPT vehicle control MDs. 
 Other key genes of interest analyzed were the growth factors EGF and IGF1, and 
proliferation marker PCNA (Fig. 3.8). There were no statistically significant differences 
in EGF expression across the treatments at stages 21, 23, or 27, but at stage 25 it was 
significantly reduced in PPT-treated tissue. IGF1 was significantly increased in PPT-
treated MD compared to all other treatments at stages 21, 23 and 25, and at stage 27 it 
was significantly higher than in FPT control MD but not compared to MPT control or 
E2-treated tissues. Differences in PCNA expression were only observed at stage 25, when 
it was significantly higher in PPT-treated tissue compared to MPT controls but not to FPT 
controls or E2-treated MD.
 The gene expression results for the 2013 samples at FPT follow similar patterns to 
what has previously been seen with these treatments (Fig. 3.9). When directly comparing 
the effects of EB vs. E2 on the expression of the transcripts assessed, the only significant 
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difference was with PGR, for which the expression level is nearly 2.5-fold greater with 
EB treatment than E2 treatment. EB treatment also increased transcript levels of ESR2 and 
AR slightly more than E2, although this was not statistically significant (Fig. 3.9).
 The combination treatments, adding WAY to PPT, were expected to attenuate the 
effects of PPT treatment alone, but this did not appear to be the case at the level of SHR 
gene expression. Effects of adding 5 µg/g EW WAY to 0.5 µg/g EW PPT and 5 µg/g EW 
PPT on the expression levels of the genes investigated were not significantly different 
than these doses of PPT alone on ESR1, ESR2, PGR and AR. There was, however, a 
significant difference between the treatments in IGF1 expression. There was nearly a 
twofold decrease in IGF1 in the combination treatments compared to the PPT treatments 
alone. 
3.4. Discussion
 The multi-stage sampling experiment provided a more in-depth look at the 
process of MD differentiation induced via PPT treatment. Alligator embryos develop 
from stage 19, the time of experimental dosing, to stage 21, the first sampling time 
point, in just 5 days at MPT (Kohno and Guillette, 2013), and already at this point PPT-
treated MDs displayed significant differences in the expression of key genes. There 
were no observable morphological or histological changes in PPT MDs at this stage, 
but PPT-induced MD phenotypic differences became more exaggerated as development 
progressed. 
The pattern of histological changes in the PPT-treated MD is similar to what 
has been seen in foundational studies on the differentiation of the avian oviduct, in 
which immature chick oviduct was treated with exogenous estrogens. Within 24 hours 
of subcutaneous injection with DES, the left oviductal magnum of 5-day-old chicks 
demonstrates substantial stromal hypertrophy due to edema (Kohler et al., 1969), similar 
to the stromal expansion seen at stage 23 in PPT-treated alligator MD. 
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In DES-treated chick luminal epithelium, the mitoses increase and the cells 
elongate, nuclei enlarge and nucleoli hypertrophy, and the cells differentiate into ciliated 
and goblet secretory cells. Secretory glands appear by day 4 as invaginations of the 
epithelium and by day 9 these glands expand into the stroma, while stromal cells at the 
periphery of the MD differentiate into bundles of smooth muscle (Kohler et al., 1969). 
The precocious glandular formation in PPT-treated alligator was first detectable at stage 
25, in which a small number of glands appear, forming from invagination of the luminal 
epithelium. At stage 27, these glands expand into the stroma in anterior regions of the 
MD, and the periphery of the MD shows smooth muscle differentiation. 
Differential histological staining utilized in this experiment supports the 
observations of regionalized differentiation of the PPT-treated MD. At stage 27, the 
PPT-treated alligator MD stained positively with AB and PAS, indicating the presence 
of mucopolysaccharide secretory products. PAS stains tissues magenta in the presence 
of a variety of mucin polysaccharides, particularly glycosaminoglycans, while AB 
selectively stains acidic mucins (Bancroft and Gamble, 2008). In the adult alligator 
oviduct, secretory products vary regionally and with reproductive status. The secretory 
epithelia stains positively with AB for glycosaminoglycans in a regional fashion: staining 
is most intense in the tube, slightly less intense in the anterior uterus and very limited in 
the posterior uterus (Palmer and Guillette, 1992). A similar pattern was seen in the stage 
27 PPT-treated MD: the luminal epithelium was positive for AB, and this was seen most 
clearly in the anterior region.
In reproductively active female alligators, between mating and oviposition, 
the oviductal luminal epithelium of the tube and anterior uterus, as well as the tubal 
glands, stain positively for PAS (Bagwill et al., 2009). PAS staining was not detected 
very strongly at all in the stage 27 PPT-treated MD epithelium, but it was strong in 
the glands of the anterior region, decreasing posteriorly. Taken together, the AB/PAS 
staining patterns seen in stage 27 PPT-treated alligator MD share some similarities 
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to those in reproductively active adult alligator FRT. This supports the idea that PPT-
induced cytodifferentiation in the embryonic alligator MD follows a regionalized pattern 
reminiscent of the highly regionalized adult FRT.
These histological similarities do not necessarily indicate that PPT-induced MD 
differentiation exemplifies the normal process of MD differentiation in the alligator. The 
hypertrophy of the PPT-treated MD stroma is indicative of edema, and smooth muscular 
differentiation of this tissue is highly disorganized. There are also clear irregularities in 
the glandulogenesis of the epithelium. Until normal FRT differentiation in alligators can 
feasibly be investigated, however, the PPT-treated MD model still provides valuable 
information about this process.
On a molecular level, SHR expression is rapidly affected by PPT treatment in 
a manner consistent with feedback regulation discussed in chapter 2. Already by stage 
21, PPT treatment results in significantly decreased expression of ESR1, and increased 
expression of PGR and AR in alligator MD compared with controls and E2 treatment. 
Interestingly, at stage 21 ESR1 and AR are strongly expressed in control MD at both 
MPT and FPT, while ESR2 and PGR and have little to no expression in control MD. 
Both PPT and E2 treatments result in increased expression of PGR and AR at stage 21, 
though E2 expression activation is to a much lesser degree. This trend continues at later 
developmental stages, supporting the hypothesis that the effects of PPT treatment on 
alligator MD are due to its selective ERα activation.
PCNA is a DNA polymerase-associated protein used as a marker of cellular 
proliferation (Helguero et al., 2005; Krishna et al., 1994).  PCNA expression has been 
used as a proliferative marker in juvenile alligator oviduct, when it was shown to increase 
following treatment with follicle stimulating hormone (FSH) (Moore et al., 2012). There 
were no differences in PCNA expression in the experiment detailed in ch.2, despite the 
dramatic size increase in PPT-treated MD compared with other treatment groups. As these 
tissues were only sampled at stage 27, it was hypothesized that PPT-induced cellular 
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proliferation occurred prior to stage 27. However, in this experiment, the only PCNA 
expression differences were seen at stage 25, and they weren’t as dramatic as would be 
expected. Based on just this marker, the role of active proliferation in the PPT-induced 
MD phenotype and the time point at which it occurs remains to be elucidated. 
The experiment involving the 2013 sample set, designed to further elucidate the 
hypothesis that the PPT-induced phenotype is due primarily to selective ERα activation, 
does not provide as much insight as expected. The effects of EB closely matched those 
of E2, and the effects of PPT treatment seen in the multi-stage experiment occurred 
relatively rapidly following administration, suggesting that the effects of PPT are not 
due to this pharmaceutical agonist having a longer half-life than endogenous estrogen. 
The lack of attenuation of the PPT treatment-induced effects by co-treatment with WAY 
contradicts the proposed hypothesis attributing the PPT-induced MD phenotype to 
imbalanced signaling between the ER isoforms.  This result may be due to factors related 
to the experimental design, however, such as the timing of dose administration and the 
doses themselves. 
At stage 19, when the treatments were administered, ESR2 transcript levels are 
not detectable via QPCR, and levels of ESR2 remain much lower than those of other 
SHRs throughout embryonic development, as shown in FPT controls in the staged 
experiment. It is therefore possible that ERβ levels in the alligator MD are too low for 
their selective activation with WAY to have downstream signaling effects strong enough 
to regulate the effects of ERα activation via PPT. 
While the pharmaceutical agonists used in this experiment were selected due 
to their specificity for ERα and ERβ via receptor transactivation assay in vitro (Kohno 
et al., 2015), the doses utilized were based on the receptor kinetics of the agonists on 
each single receptor isoform in isolation, rather than the co-existence of both of the ER 
isoforms in vivo. Taken alongside the observed differences in receptor isoform expression 
levels in the embryonic MD, it is highly likely that the dosage of WAY used here was not 
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enough to induce a level of ERβ activation that could counter the highly activating effects 
of PPT on ERα. 
Even so, the effects of combinatorial treatment on IGF1 expression provide some 
support for the concept of a regulatory role of ERβ on ERα-mediated proliferation in 
the alligator MD. The attenuated IGF1 levels made no difference in the PPT-induced 
hypertrophy, however, but these transcripts were only measured at stage 27. The multi-
stage experiment showed that PPT-induced hypertrophy begins much earlier, and PPT-
induced increases in IGF1 levels are more dramatic at earlier developmental stages, while 
transcript levels of ESR2 increase over developmental time. An experiment incorporating 
a later dosage time, or multiple doses over a developmental time course, might better 
elucidate the interplay between ERα and ERβ signaling in proliferative and differentiative 
processes in alligator MD.
Taken together, the results of these experiments support the value of the PPT-
induced MD phenotype as a tool for investigating the role of estrogen signaling in the 
developing alligator FRT, even if the different effects of PPT treatment and E2 treatment 
may be due to some unknown aspect of PPT metabolism in the embryonic alligator. The 
response of embryonic alligator MD to PPT follows a similar pattern to the response 
of the developing avian FRT to estrogens. This response, particularly at a molecular 
signaling level, provides insight into the role of estrogen signaling in developing alligator 
FRT, but further experiments are needed to elucidate the specific roles of the estrogen 
receptor isoforms in proliferation and differentiation in the developing alligator FRT. 
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Fig. 3.1 Schematic of experimental designs.
Time points of dosing and collection relative to the thermosensitive period (TSP) 










































































































































































































































Fig. 3.3. Effects of treatment on gonadal histology at stage 27.
Representative cross sections of stage 27 alligator GAM complexes.(A) 0.5 μL/g EW EtOH at 
FPT. (B) 0.5 μL/g EW EtOH at MPT. (C) 0.5 μg/g EW E2 at MPT. (D) 5 μg/g EW PPT at MPT. 
G = gonad, M = metanephros. sc = sex cords. Arrows indicate ovarian lacunae. Dashed line 











































































































































































































































































Fig. 3.5. Regionalized histological and histochemical characteristics of stage 27 PPT-treated embryonic Müllerian duct.
Representative cross sections of stage 27 5 μg/g EW PPT-treated MPT MD. (A) Trichrome 
stained anterior region of MD. (B) Trichrome-stained, more posterior region of MD. (C) and (D): 
similar regions stained with AB/PAS. (E) and (F): magnifications of (C) and (D), respectively. 











































































































































































Fig. 3.7. Effects of PPT treatment on steroid hormone receptor expression in Müllerian duct at 
four developmental stages.
Relative expression of SHRs normalized to calculated normalization factor. Error bars indicate 
mean standard error. Genes indicated to left of graphs, from top to bottom: ESR1, ESR2, PGR, 
AR. Stage of collection above, from left to right: 21, 23, 25, 27. Bar color indicates treatment: 
black = 0.5 µl/g EW EtOH, MPT; white = 0.5 µl/g EW EtOH, FPT; dark gray = 0.5 µg/g EW 
E2; light gray = 5 µg/g EW PPT. p-values via one-way ANOVA indicated above graphs. 
Sample size indicated below bars.  Letters above bars indicate differences among treatment 
groups per Tukey’s multiple comparison post hoc test.
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Fig. 3.8. Effects of PPT treatment on growth factor expression in Müllerian duct at four developmental stages.
Relative expression of target gene normalized to calculated normalization factor. Error bars 
indicate mean standard error. Genes indicated to left of graphs, from top to bottom: EGF, IGF1, 
PCNA. Stage of collection above, from left to right: 21, 23, 25, 27. Bar color indicates treatment: 
black = 0.5 µl/g EW EtOH, MPT; white = 0.5 µl/g EW EtOH, FPT; dark gray = 0.5 µg/g EW 
E2; light gray = 5 µg/g EW PPT. p-values via one-way ANOVA indicated above graphs. Sample 
size indicated below bars.  Letters above bars indicate differences among treatment groups per 
Tukey’s multiple comparison post hoc test.
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Fig. 3.9. Effects of combinatorial treatments of PPT and WAY on expression of genes of interest 
in stage 27 Müllerian duct
Expression values reported as relative expression normalized to ACTB. Error bars indicate mean 
standard error. Treatment indicated below bars. p-values via one-way ANOVA indicated above graphs. 
Sample size indicated below bars.  Letters above bars indicate differences among treatment groups per 
Tukey’s multiple comparison post hoc test.
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CHAPTER 4: 
The influence of background contaminant exposure on embryonic Müllerian duct 
response to in ovo stimulation with estrogen and ERα selective agonist PPT
4.1. Introduction
The American alligator has become a recognized wildlife model for studying the 
effects of developmental exposure to environmental endocrine disrupting contaminants in 
large part due to more than two decades of research on a population living in Lake Apop-
ka, FL, a site of known heavy contamination with the pesticide DDT.  The area around 
Lake Apopka has been used heavily for water-intensive agriculture known as muck 
farming, and DDT was used extensively on these fields until its ban in 1972 (Conrow et 
al., 2011). In 1980 there was a major spill of DDT into the lake from a nearby pesticide 
manufacturing plant (United States Environmental Protection Agency, 1994). In 1981, a 
significant decline in the population of juvenile alligators in Lake Apopka was observed, 
along with significantly depressed egg viability rates and hatching success compared with 
other Florida lakes (Woodward et al., 1993; Woodward et al., 2011). 
Over the years, measurements of DDT and its metabolites, especially p,p’–DDE, 
have been higher in alligator eggs and tissues from Lake Apopka compared with other 
Florida lakes (Heinz et al., 1991; Rauschenberger et al., 2004; Woodward et al., 2011).  
DDE bioaccumulates in adipose tissue and thus levels remain consistent in populations 
over long time periods, and can increase in individuals chronically exposed over a long 
lifespan (Turusov et al., 2002). These types of adipose-accumulated contaminants can be 
transferred directly from mother to offspring when lipids are mobilized to produce nutri-
tive breastmilk or yolk (reviewed in Hamlin and Guillette, 2011).  This type of maternal 
transfer occurs in Apopka alligators, as DDT, DDE and other contaminants have been 
detected in both egg yolk and in maternal tissue (Rauschenberger et al., 2004; Rauschen-
berger et al., 2007). DDE at levels detected in yolk from Lake Apopka eggs has been 
shown to interact with alligator oviductal protein extract in competitive binding assays 
with estrogen or progesterone (Vonier et al., 1996).
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Many anomalies have been documented in Apopka alligators compared with 
alligators from reference sites with lower measured contaminant levels. For most of these 
studies, Lake Woodruff National Wildlife Refuge has served as the reference site, as it has 
historically had fewer anthropogenic influences than Lake Apopka, as well as measurably 
lower levels of contaminants, and the alligator population has had much greater reproduc-
tive success (Milnes and Guillette, 2008). Egg viability rates and hatching success have 
remained consistently lower for Apopka than Woodruff (Guillette et al., 2000; Milnes 
and Guillette, 2008) and in studies where eggs were hatched out and maintained under 
identical laboratory conditions, Apopka alligators had higher post-hatching mortality than 
Woodruff alligators (Milnes et al., 2008). There have been several major morphologi-
cal and physiological differences documented in alligators between these sites. Juvenile 
alligators in Lake Apopka had significantly decreased phallus size with lower plasma 
testosterone compared to Lake Woodruff (Guillette et al., 1996). Six-month-old alliga-
tors hatched from eggs collected at Lake Apopka and raised under controlled laboratory 
conditions exhibited disrupted gonadal morphology, most notably, multi-oocytic ovarian 
follicles reminiscent of those seen in mice exposed in utero to DES (Guillette et al., 1994; 
Guillette and Moore, 2006). 
Molecular signals were investigated to probe the potential mechanisms underlying 
these ovarian alterations in Apopka alligators. Gonadal ESR2 expression was higher in 
field-captured juvenile alligators in Lake Woodruff than in Lake Apopka (Kohno et al., 
2008) and also in 13-month-old alligators collected as eggs from the field sites and reared 
under controlled laboratory conditions (Moore et al., 2010b). Laboratory-reared juvenile 
alligators collected as eggs from Lake Woodruff exhibited sexually dimorphic expression 
patterns of important genes involved in steroidogenesis and members of the transforming 
growth factor β (TGF-β) superfamily that promote and regulate ovarian follicle develop-
ment, while juveniles collected as eggs from Apopka and raised under identical labora-
tory conditions did not (Milnes et al., 2008; Moore et al., 2011). At hatch, neonates from 
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Lake Apopka had lower gonadal expression of these ovarian folliculogenesis-regulating 
TGF-β factors than neonates from Lake Woodruff (Moore et al., 2010a). As measured by 
expression levels of folliculogenesis-regulating factors and steroidogenic enzyme aro-
matase, Apopka neonates exhibited a decreased response to challenge with FSH com-
pared with Woodruff neonates (Moore et al., 2010a), a difference which persisted five 
months post-hatch (Moore et al., 2012).
These differences in morphology and molecular signaling in gonads of alligators 
from Apopka suggested this developmental exposure could also induce alterations in 
FRT. There are no reported differences in FRT morphology between Apopka and Wood-
ruff alligators, but there are noticeable differences in eggs collected from these sites. Over 
the years we have collected eggs and incubated them in our laboratory, we have anecdot-
ally noted Apopka eggs are smaller in size and weight than Woodruff eggs, and we have 
also observed malformed eggs from Apopka (unpublished observations). This suggests 
there may be impairments in reproductively mature Apopka FRT structure or function 
that impact egg production. 
DDT and its metabolites have been famously implicated in major reproductive 
tract disorders in birds, particularly the phenomenon of eggshell thinning. In multiple, 
primarily carnivorous species, including pelicans, bald eagles, cormorants and herring 
gulls, decreased hatching success and significantly thinner eggshells (>15% reduction) 
were positively associated with levels of DDE in eggs, and laboratory exposure experi-
ments confirmed eggshell thinning in birds exposed to DDE (Cooke, 1973). The mech-
anism of DDE-induced eggshell thinning is still under investigation. Originally it was 
thought that DDE interfered with prostaglandin synthesis in the shell gland of the avian 
oviduct, thus inhibiting calcium transport (Lundholm, 1997). More recent studies have 
shown that embryonic exposure to DDE can directly disrupt the development of the avian 
FRT, resulting in altered shell gland function and eggshell thinning (Holm et al., 2006; 
Kamata et al., 2009). Thus, exposure to DDE during a critical developmental window 
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may induce adverse impacts observed in birds, and alligators from Lake Apopka may be 
similarly susceptible to disrupted FRT development due to DDE exposure.
 We have established that the developing alligator FRT is receptive to estrogenic 
stimulation via ERα, and treatment with the ERα agonist PPT induces hypertrophy and 
cellular differentiation in the MD. In vitro receptor transactivation assays have shown that 
DDT and DDE are human ER agonists, with greater activity on hERα than hERβ (Koji-
ma et al., 2003).  DDT and DDE also activate alligator ERα in in vitro receptor transac-
tivation assays, though their effects on ERβ have not been assessed (Rider et al., 2010).  
Thus, exposure to DDE and other EDCs in Apopka alligators could lead to disrupted FRT 
development via selective stimulation of ERα.
Our previous investigations of the effects of ER isoform selective agonists on 
alligator MD provide a unique tool for testing this hypothesis. We have characterized the 
MD response to selective ERα activation via in ovo PPT treatment in alligator embryos 
from the relatively pristine environment of Lake Woodruff. Here we investigate whether 
background exposure to EDCs alters this ERα-mediated MD response by treating alliga-
tor embryos collected from Lake Apopka with PPT. We directly compare the morpholog-
ical, histological and transcriptional effects of in ovo PPT treatment on MD in alligator 
embryos from Lake Apopka and Lake Woodruff.
4.2. Materials and methods
4.2.1. Egg collection, incubation and treatment
All experiments in this study involving alligators were carried out under the pro-
tocol approved by the Institutional Animal Care and Use Committee at the Medical Uni-
versity of South Carolina, and all fieldwork was conducted under permits from the Flori-
da Fish and Wildlife Conservation Commission and the U.S. Fish and Wildlife Service.
 Alligator eggs were collected from Lake Woodruff National Wildlife Refuge (De 
Leon Springs, FL, USA) on 6/20/2013 and Lake Apopka (Lake and Orange Counties, FL, 
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USA) on 6/21/2013 under Florida Fish and Wildlife Conservation Commission permits. 
Eggs were transported to MUSC facilities (Charleston, SC, USA), weighed, candled, 
staged and incubated at 30°C as described in the preceding chapters. 
At stage 19, eggs were randomly assigned to treatment groups: 0.5 μL/g egg EW 
absolute ethanol; 0.5 μg/g EW E2 (Sigma-Aldrich, St. Louis, MO, USA); 0.5 μg/g EW 
or 5 μg/g EW PPT (Tocris Bioscience, Bristol, UK), prepared as described in previous 
chapters. Doses were based on the previous experiments, in which these doses of PPT 
produced significant differences in MD morphology, histology and gene expression as 
compared with the vehicle control and E2 treatment. Treatments were administered by 
eggshell painting as previously described, and embryos were incubated at FPT for the 
duration of the experiment.
Using the methodology shown in chapter 2, embryos were sacrificed at stage 27 
and left and right GAM-MD complexes were collected under a dissecting microscope, 
the right side preserved in RNAlater® (Life Technologies, Grand Island, NY, USA) and 
the left side in 4% PFA. The fixed tissues were incubated overnight on a shaker at 4°C. 
The RNAlater® -preserved tissues were then stored at -20°C. The PFA-fixed tissues were 
progressively dehydrated in methanol/PBST over a 24-hour period and stored in 100% 
methanol at -20°C.
4.2.2. Histology
PFA-fixed tissues were dehydrated through a series of isopropanol and xylene and 
paraffin infiltrated using a Leica ASP300 autoprocessor (Wetzlar, Germany), and embed-
ded into paraffin using a Leica EG1150C embedder. Tissues were serially cross-sectioned 
or serially lateral-sectioned at 8 µm using a Leica manual rotary microtome, and stained 




For each treatment group, five samples were examined in full, 2-3 as serial cross 
sections and 2-3 as serial lateral sections. As in previous chapters, the anterior-posterior 
axis of the GAM was utilized as a metric for assessing regionalization of the MD. Repre-
sentative digital photomicrographs were taken of cross-sectioned samples with a ProgRes 
Speed XT core 5 camera (Jenoptik, Jena, Germany) of a region near the anterior end of 
the GAM, where both the gonad and adrenal gland are present. 
4.2.3. RNA isolation, cDNA synthesis and quantitative PCR
 The methods for RNA extraction, cDNA synthesis and QPCR are similar to previ-
ous chapters, with minor modifications. RNAlater® -preserved MD tissues were manu-
ally separated from GAM complexes under a dissecting microscope and stored at -20°C 
until RNA extraction.  Whole MDs (n=8 per treatment group) were homogenized for 
RNA extraction via the SV Total RNA Isolation System with DNase-I treatment (Prome-
ga, Fitchburg, WI, USA). RNA concentration was measured using a Nanodrop Spec-
trophotometer (Thermo Scientific, Wilmington, DE, USA) and quality was assessed via 
denaturing agarose gel electrophoresis. RNA was diluted to matching concentrations and 
reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit with RNase 
Inhibitor (Applied Biosystems, Foster City, CA, USA) per manufacturer’s protocol, using 
10 μL diluted RNA in 20 μL total reaction mix,  and the cDNA was diluted 1:5 in nucle-
ase-free water.
QPCR was performed using a CFX96 real-time system (Bio-Rad, Hercules, CA, 
USA). Reactions were performed in triplicate using 0.01 U/μl AmpliTaq Gold (Applied 
Biosystems, Carlsbad, CA, USA) and a SYBR green reaction master mix consisting of 
20mM Tris-HCl (pH 7.75), 50mM KCl, 3mM MgCl2, 4% DMSO, 0.5x SYBR Green 
I (Thermo Fisher Scientific, Grand Island, NY, USA), 0.5% glycerol, 0.5% Tween 20, 
0.2mM deoxynucleotide mix (Thermo Fisher Scientific), 0.2 µM of each primer mix (Eu-
rofins Genomics, Huntsville, AL, USA), and 1/25 volume diluted cDNA. 
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The thermal cycler program consisted of an initial denaturation step (95°C, 5 min) fol-
lowed by 45 cycles of denaturation (95°C, 15 s) and annealing and elongation at an 
optimized temperature (45 s – 1 min, depending on primer set). After the final cycle, a 
dissociation curve was generated for each reaction to assess the reaction specificity via an 
incremental heating step (+0.5°C/5 s).
Primer sequences, product size and optimal annealing temperatures are listed in 
Table 1 (pg. 28). Prior to analysis of unknown samples, the specificity of each primer 
pair was confirmed by product sequencing. Plasmid DNA standard curves of known copy 
number were generated with these sequenced products. Each 96-well plate of unknown 
samples included a standard curve, and all samples, including those of the non-template 
control and standard curve, were run in triplicate.  Mean expression values of mRNA for 
each target gene were normalized to that of beta-actin (ACTB). 
4.2.4. Statistical analysis
QPCR data were collected and analyzed using CFX Manager version 3.0 software 
(Bio-Rad).  After determining that expression of ACTB was not significantly affected by 
treatment or site (Apopka vs. Woodruff) via two-way analysis of variance (ANOVA), 
expression values of all other genes of interest were normalized to ACTB. Data were 
log-transformed to achieve homogeneity of variance. Two-way ANOVA was utilized to 
calculate the effects of treatment and site on expression of genes of interest. Outlying 
values were removed by examination of a residual plot and a distribution plot of the 
transformed data. Significance was set at p < 0.05, and a Tukey’s multiple comparison 
post-hoc test was used to detect differences among treatment groups. 
All statistical analysis was performed using both JMP12 (SAS Institute, Inc., 




4.3.1. Morphometric differences between eggs and embryos from Lake Woodruff and 
Lake Apopka are not influenced by treatment
 In the clutches of eggs utilized in this experiment, fertility rate was not signifi-
cantly different between the sites, with 96% fertility for Lake Woodruff and 94% for Lake 
Apopka. As embryos were sacrificed prior to hatching, hatch rate could not be deter-
mined, but there was no significant difference between sites in mortality over the course 
of the experiment between dosing at stage 19 and sacrifice at stage 27 (n = 1 for Apopka 
and n = 2 for Woodruff).  When eggs were initially brought to the laboratory and candled 
for viability, they were weighed, and there was no difference in mean egg weights be-
tween the sites for the particular clutches utilized in this experiment.
 At time of sacrifice, eggs and embryos were weighed, and there was a significant 
difference in egg mass between Woodruff and Apopka (Woodruff = 90.3  0.089g, Apop-
ka = 80.9  0.084g, two-tailed p < 0.0001). There was no significant difference in em-
bryo mass, however (Woodruff = 35.5  0.9 g, Apopka = 33.6 0.06 g, two-tailed t test p = 
0.089). 
4.3.2. PPT treatment induces similar changes in Müllerian duct morphology and histolo-
gy in embryos from both Lake Woodruff and Lake Apopka
 PPT treatment induced the same MD gross morphology in this experiment as 
previously described in chapter 2 (as shown in Fig. 2.1). Compared with MD of controls 
and E2 treatment, the MD of stage 27 embryos was massively enlarged in embryos treated 
with 5 μg/g EW PPT, and somewhat enlarged in embryos treated with 0.5 μg/g EW PPT. 
Within treatment groups, there were no appreciable differences between Woodruff and 
Apopka embryos at stage 27. PPT-treated MDs were weighed prior to RNA extraction for 
the purposes of proper reagent calculation, and MD masses between Woodruff and Apop-
ka samples was not significantly different (Woodruff = 51.38  7.84 g, Apopka = 35.75  
4.02 g; two-tailed t-test p  = 0.098).
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 The histological findings were also consistent with what was described in chap-
ter 2. In the vehicle control samples and the E2-treated samples, the stage 27 MD was a 
simple tube with a columnar epithelium surrounding the lumen and a fibroblastic mesen-
chymal stroma (Fig.  4.1 A-D). Treatment with 0.5 μg/g EW PPT induced enlargement 
of the MD that involved stromal hypertrophy, as described in ch. 2, in both Woodruff and 
Apopka samples (Fig. 4.1 E, F). At the highest dose, 5 μg/g EW, PPT treatment induced 
the phenotype of MD hypertrophy with precocious glandular differentiation detailed in 
previous chapters. There were no observable differences between Apopka and Woodruff 
embryos at stage 27 in this treatment group (Fig 4.1. G, H).
 
4.3.3. PPT treatment induces similar changes in expression of genes of interest in Mülle-
rian duct in embryos from both Woodruff and Apopka
 As in previous experiments, PPT treatment induced significant changes in expres-
sion of SHRs and IGF1 compared with vehicle control and E2 treatment (Fig. 4.2) 
 Treatment with 5 μg/g EW PPT reduced MD ESR1 about fourfold in both Wood-
ruff and Apopka samples compared with control and E2-treated samples. ESR1 was 
somewhat reduced in 0.5 μg/g EW PPT-treated Woodruff MD samples, but not in Apop-
ka samples.  ESR2 was increased in 0.5 μg/g EW and 5 μg/g EW PPT-treated samples 
compared to controls, in both Woodruff and Apopka MDs. This increase was greater 
in samples from Apopka than in Woodruff, with a five-fold increase in ESR2 expres-
sion in PPT-treated Apopka MDs compared to controls, and only a two-fold increase in 
PPT-treated Woodruff MDs compared to controls. 
 PPT treatment significantly increased expression of PGR compared to controls 
and E2 treatment in both Woodruff and Apopka MDs. While PGR levels were similar in 
both 0.5 μg/g EW and 5 μg/g EW PPT-treated Woodruff samples, in Apopka samples, 5 
μg/g EW PPT treatment induced significantly higher PGR expression than 0.5 μg/g EW 
PPT treatment. 
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 For both AR and IGF1, expression was significantly higher in PPT-treated MDs 
than controls or E2-treated MDs in both Woodruff and Apopka samples, with no signifi-
cant differences between the sites. 
4.4. Discussion
Overall, the MD response to PPT treatment in Apopka embryos was very simi-
lar to that of Woodruff embryos. There are no previously documented morphological or 
histological differences between MDs or immature oviducts from Apopka and Woodruff 
alligators, which is unsurprising in light of our findings documented in previous chapters. 
The developing alligator MD only exhibits morphological changes through in ovo treat-
ment with extreme doses of estrogens or progestins (Austin, 1991; Lang and Andrews, 
1994) or via selective activation of ERα as our experiments have shown. DDE and other 
contaminants present in Apopka egg yolk are unlikely to be as highly endocrine active. 
Indeed, DDT and its metabolites were shown to have low affinity for alligator oviductal 
protein extract in competitive binding assays with estrogen and progesterone, although 
mixtures of contaminants found in Apopka eggs had a greater than additive effect (Vonier 
et al., 1996). In vitro receptor transactivation assays also showed DDT and DDE were 
weakly activating of alligator ERα (Rider et al., 2010). Experimental treatment of alliga-
tor embryos from Lake Woodruff with 100 ppb DDE increased female:male sex ratio at 
the intermediate incubation temperature, but did not alter MD morphology or MD epithe-
lial cell height (Milnes et al., 2005).
No major oviductal differences have been reported in adult Apopka alligators, 
but differences in egg mass, morphology, viability and hatching success have all been 
documented. While eggshell thinning has been highly correlated with DDE exposure in 
birds, no studies support DDE-induced eggshell thinning in alligators. In 1985, there was 
no significant difference found between shell thickness of eggs from Lake Apopka and a 
reference site, and there was even a slight positive correlation between DDE residues in 
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eggs and eggshell thickness (Heinz et al., 1991). A multi-year study of eggshells collected 
after laboratory hatch-out found Apopka eggs actually had thicker shells than Woodruff 
eggs (Bryan, 2005). 
While the levels of DDE measured in alligator eggs in Lake Apopka are consis-
tently higher than those measured at other sites, they are lower than levels documented 
in bird populations that were significantly impacted by DDE-induced eggshell thinning. 
Between 1984 and 2002, DDE levels in Apopka alligator eggs were measured several 
times and average levels ranged from 3.5 - 5.8 ppm (Heinz et al., 1991; Rauschenberger 
et al., 2007; Woodward et al., 2011).  A study of bald eagles suffering a serious DDT-as-
sociated population decline in Ontario reported levels of DDE in eggs as high as 94 ppm 
prior to the ban of DDT, and by1981 levels had dropped to a mean of 29 ppm and both 
hatching rate and eggshell thickness had improved significantly (Grier, 1982).  However, 
avian FRT anomalies have been documented at lower levels of DDE exposure as well.  In 
brown pelicans, 4 - 5 ppm DDE in eggs was correlated with 15% eggshell thinning, and 
reproductive impairment occurred above 2.5 ppm (Blus et al., 1974). 
More recent laboratory studies have directly correlated in ovo exposure to DDT 
with changes in reproductive system patterning that lead to eggshell thinning in chickens 
(Holm et al., 2006) and Japanese quail (Kamata et al., 2009). This impairment in oviduc-
tal function is accompanied by obvious structural changes including foreshortening of the 
left oviduct and retention of all or part of the right oviduct, which normally completely 
regresses in these birds (Holm et al., 2006; Kamata et al., 2009). These types of oviductal 
anomalies are also seen in birds following in ovo exposure to other estrogens and estro-
genic contaminants such as DES, ethinyl estradiol, EB and bisphenol A (Berg et al., 1999; 
Brunstrom et al., 2009; Halldin, 2005; Rissman et al., 1984).
Taken together, it is appears that alligator MD differs from avian MD in respon-
siveness to estrogenic stimulation. It takes a large, imbalanced ERα stimulation to induce 
observable morphological changes in alligator MD similar to those observed in avian 
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studies utilizing much lesser estrogenic stimuli. However, the alligator MD does show 
estrogenic treatment-induced alterations on a more subtle molecular level. In a study of 
5-month-old laboratory-reared alligators, FSH challenge elicited an increase in transcript 
levels of PGR and AR in oviducts from animals collected as eggs from Lake Woodruff 
and not in those from Lake Apopka. In this study, we also found subtle differences in 
SHR expression between Woodruff and Apopka alligators, with Apopka alligators exhibit-
ing larger PPT treatment-induced increases in ESR2 and PGR.
 In previous chapters we have posited that ESR2 and PGR expression is altered by 
PPT treatment as a feedback response, as negative regulators of ESR1 signaling. The dif-
ferences in PPT-induced expression changes of these genes in Apopka embryos compared 
with Woodruff embryos suggests there may be alterations in steroid hormone regulatory 
responses in Apopka alligators. 
 In conclusion, developmental exposure to endocrine disrupting contaminants at 
ecologically relevant doses, as represented by yolk contaminants in embryos from Lake 
Apopka, does not have any observable impacts on the developing alligator MD. Howev-
er, this background exposure can result in altered molecular signaling responses to addi-
tional endocrine stimulus, such as the treatment regime in this experiment. The repercus-
sions of this altered response on FRT function and, by extension, the overall reproductive 
health of alligators, is not known and requires further investigation. 
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Fig. 4.1. Effects of PPT treatment on histological characteristics of stage 27 Müllerian duct in 
alligators from a reference site vs. those from a site of known contamination.
Representative cross sectional photomicrographs of FPT stage 27 alligator GAM and MD from 
Lake Woodruff (left) and Lake Apopka (right). Treatments indicated to the left of images, from top 
to bottom: 0.5 µL/g EW EtOH, 0.5 µg/g EW E₂, 0.5 µg/g EW PPT and 5 µg/g EW PPT. Stained 
with H&E. Scale bars = 100 μm
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Fig. 4.2 Effects of PPT treatment on expression of genes of interest in stage 27 Müllerian duct 
from alligators from a reference site vs. those from a site of known contamination.
Expression values reported as relative expression normalized to ACTB. Error bars indicate 
mean standard error. Treatment indicated below bars. Black bars = Lake Woodruff samples, 
white bars = Lake Apopka samples. p-values via two-way ANOVA indicated above graphs. 
Sample size indicated below bars.  Letters above bars indicate differences among treatment 





The overarching goal of this dissertation research was to investigate the develop-
ment of the female reproductive tract of the American alligator in the context of endo-
crine disruption.  The endocrine disruption hypothesis has become an established para-
digm guiding investigations that are critical for the health of humans and all other life on 
the planet, which makes it by necessity broad and transdisciplinary. The foundations of 
this field are “basic science” investigations, however; and when I entered graduate school 
and expressed my lofty aims to my mentor, Dr. Louis Guillette, I quickly learned one of 
his most often-repeated maxims,  “You can’t understand ‘abnormal’ until you understand 
‘normal.’” 
In the case of alligator FRT development, “normal” was far from established. 
Studies on alligator reproductive physiology examined mature FRT and positioned the 
alligator FRT as closer, from an evolutionary standpoint, to birds than to other reptiles, 
though it displayed characteristics of both (Palmer and Guillette, 1992). There is a dearth 
of studies on the developmental differentiation of alligator FRT, ostensibly due to the 
difficulty of studying a slow-maturing, long-lived, large predator. 
The embryonic alligator MD is a simple, uniform tube. The only documented 
regional difference in normal female alligator MD was discussed in ch. 2: the MD region 
at the posterior terminus of the adrenal gland of the GAM displays a thickened luminal 
epithelium. This characteristic is only present for a very short portion of the MD, and its 
significance is unknown, but it was consistently seen in all FPT control MD, suggesting 
that it is a normal characteristic of developing alligator FRT (Doheny et al., 2016). The 
age at which the alligator FRT normally becomes regionally differentiated under natural 
conditions is unknown. Differentiation of the oviduct has not been reported in any labora-
tory studies involving untreated female alligators reared from hatching until as old as 1.5 
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years of age (Forbes, 1938b). In my own experience necropsying female alligators reared 
for about 6 months post-hatch in the laboratory, until they had attained one kg body mass, 
the oviducts were simple, thin tubes for nearly their entire length, with some sinuous 
curving at the anterior end. Histologically, no major differences were seen in serial cross 
section or in lateral sectioning of coiled tissues; the oviducts were similar to the embryon-
ic MD, with a central lumen surrounded by a simple columnar epithelium and a fibroblas-
tic stroma. 
The age at which alligators are reproductively mature is variable, ranging from 
10-18 years, depending on temperature and nutrient availability (Lance, 2003). The more 
important determinant of maturity is body size, and the most reliable, standardized mor-
phometric used in studies of alligator populations is the length from the tip of the snout 
to the vent (SVL). Alligators attain reproductive maturity at a SVL of 90 cm (Wilkinson 
and Rhodes, 1997).  From the aforementioned unpublished study we conducted in which 
alligators were hatched out and reared in the lab until they reached one kg in mass, the 
average SVL at hatch was 12.3 ± 0.4 cm, and the SVL at sacrifice was 33.5 ± 0.9 cm. 
There is some evidence to suggest that alligators enter peripubescence above a threshold 
size of approximately 38 cm SVL, as wild juvenile alligators begin to show pronounced 
seasonal variation in circulating sex hormones (Rooney et al., 2004). Thus, differentiation 
of the alligator oviduct normally occurs after it becomes prohibitive to maintain alligators 
in the laboratory due to their size, and likely involves hormone signaling during a puber-
tal phase. 
While still pondering the best methods for studying alligator FRT development 
given this major limitation, as part of a different study aimed at investigating gonadal sex 
determination we unexpectedly induced a hypertrophied MD phenotype heretofore never 
seen in our research group. This experimentally-induced phenotype, while not a direct 
reflection of “normal” FRT development, nevertheless provided a model for investigating 
how the embryonic MD responds to estrogenic stimulation, and the implications of this 
response for the process of normal FRT differentiation.
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Over the course of this investigation, I established the basic characteristics of the 
MD phenotype induced via treatment with the selective ERα agonist PPT. The massive 
MD enlargement easily observed with the naked eye during necropsy was examined at a 
histological level, initially to determine whether this enlargement was due to hypertrophy 
or hyperplasia. I discovered that while there was hypertrophy of stromal cells, the more 
striking characteristic was differentiation of luminal epithelial cells into glandular struc-
tures similar to the process of adenogenesis in the mammalian and avian FRTs. Numerous 
studies have detailed induction of glandular formation in avian and mammalian FRT by 
developmental exposure to endogenous and exogenous estrogens and estrogenic contami-
nants (reviewed in Dougherty and Sanders, 2005; Kurita, 2011). My discovery of glandu-
logenesis in embryonic alligator MD is thus not unique if considered in the context of the 
FRT development in amniotes, but the intriguing aspect of it is that only treatment with a 
pharmacological selective agonist of ERα induced this glandulogenesis. As detailed in the 
introduction, previous studies involving treatment with E2, synthetic estrogens, or estro-
genic compounds, did not induce this response in alligators (Austin, 1989, 1991; Forbes, 
1938b). Both the developing mammalian and avian FRTs seem much more labile to es-
trogen signaling than the alligator, as major FRT structural changes have been reported in 
birds and mammals following embryonic exposure to estrogens (reviewed in Dougherty 
and Sanders, 2005; Iguchi, 2000; Kurita, 2011).
The novelty of the PPT-induced phenotype in alligator MD could well be due to 
the fact that alligators are simply not that well-studied; if the alligator was a more popular 
and accessible model, more rigorous testing of endocrine active compounds during alliga-
tor development might have resulted in other incidences of this phenotype. Alternatively, 
the factors determining alligator FRT differentiation could be quite different from those 
guiding differentiation in more well-studied models with genetic, rather than environmen-
tal, sex determination. In mammals, where SRY on the Y chromosome guides male sex 
determination, the XX female is considered the “default” state, with ovarian differentia-
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tion occurring in the absence of SRY, and FRT differentiation occurs in a similar default 
fashion, in the absence of male-determining endocrine factors (Gilbert, 2000; vom Saal et 
al., 1992). In birds, the ZW female only receives a “half-dose” of the Z-linked male-de-
termining factor DMRT1, and thus ovarian differentiation also occurs in the absence 
of the male signal (Smith et al., 2009). Designating FRT differentiation as a the default 
system in birds is a more complicated picture than in mammals, however, as AMH is 
produced in both males and females, and ovarian estrogens are necessary for protecting 
the FRT against AMH-induced degeneration (Hamilton, 1961). This begs the question: 
in alligators and other animals with temperature dependent sex determination, is there a 
“default” system? What factors actually drive reproductive tract differentiation?
Interestingly, studies have demonstrated that estrogens administered prior to the 
thermosensitive window of sex determination can induce ovarian development in alli-
gators incubated at MPT, indicating that estrogens can override the male-determining 
thermal signal, while thus far no androgenic treatment has induced testis development at 
FPT (Kohno and Guillette, 2013; Lance and Bogart, 1992). This may indicate that fe-
male is the “default” state in alligators, i.e., in the absence of a male-determining signal, 
female differentiation occurs. This idea is supported by the fact that there is a much larger 
range of temperatures that bias female differentiation in the alligator and a larger window 
of time in which these temperatures can bias toward female sex determination (Kohno 
and Guillette, 2013; McCoy et al., 2015).  Once gonadal differentiation has occurred, 
testis-produced AMH leads to MD degeneration, which is completed prior to or not long 
after hatch out, whereas in the female, the MD is maintained but remains undifferentiated 
until much later. Experimental evidence suggests that estrogen can be protective against 
MD regression in alligators, but is not necessary in normal female development. When 
female neonates were ovariectomized and given a graft of testicular tissue, the MDs 
regressed, but MD regression did not occur in ovariectomized neonates given a graft of 
muscular tissue, nor in ovariectomized, testis-grafted females implanted with a slow-re-
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lease pellet of E2 (Austin, 1989). Thus, perhaps the best descriptor for the developing 
alligator FRT is not “default” but rather “passive,” as it can be responsive to exogenous 
estrogen stimulation, particularly via ERα, but does not need estrogenic signals during 
embryonic development. The immature FRT remains undifferentiated until it receives the 
appropriate signal driving regionalized cytodifferentiation at a much later developmental 
time point.    
5.2. Future directions
 A role for estrogen signaling in this later regionalized differentiation of the alliga-
tor FRT is strongly suggested by experiments described in the previous chapters charac-
terizing the regionalized cytodifferentiation of the MD induced by in ovo PPT treatment. 
Across all of the experiments described, stage 27 alligator MD treated at stage 19 with 5 
μg/g EW PPT had a greater density of glandular structures in the anterior portion of the 
MD, decreasing posteriorly. This could be due to the treatment operating on an anteri-
or-posterior gradient, and having a stronger effect on the anterior regions, or it could be 
due to underlying factors guiding regional differentiation of the FRT.  The adult alligator 
FRT is highly regionalized, and the anterior tube similarly displays the greatest density of 
glands (Palmer and Guillette, 1992). Many genetic factors have been identified that are 
involved in regional differentiation of the mammalian FRT (Kobayashi and Behringer, 
2003) and it would be worthwhile to investigate similar factors in alligator FRT differen-
tiation.  
In investigations of these regulatory factors involved in FRT differentiation, a target 
of particular interest are the Homebox (Hox) genes, due to their ubiquity in axis-deter-
mining patterns in embryos. As mentioned in chapter one, regional expression of the 
Hoxa 5’ genes correlate with the regional differentiation of the FRT in mammals (Ma 
et al., 1998; Taylor, 2000), and experimental evidence suggests that estrogens regulate 
regional expression of Hoxa 5’ genes in the developing FRT (Akbas et al., 2004). Devel-
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opmental exposure to the synthetic estrogen diethylstilbestrol in mice results in a poste-
rior shift of Hoxa9, Hoxa10 and Hoxa11 gene expression, and reproductive tract abnor-
malities indicative of a posterior shift of specialized structures (Block et al., 2000; Ma et 
al., 1998).  Thus, future investigation into the effects of treatment with E2 and estrogen 
receptor-selective agonists on Hox gene expression in specific regions of the alligator 
MD could be valuable in better understanding regional patterning of FRT differentiation 
in alligators and other vertebrates.
Further, a greater understanding of the molecular mechanisms underlying the 
development of the alligator oviduct could inform general understanding of the evolution 
of viviparity. Hoxa10 has been shown to have an important role in successful implanta-
tion and maintenance of pregnancy in mammals, which has led to investigations into its 
role in structural adaptations associated with the transition from oviparity to viviparity. 
Hoxa10 knockdown in cycling mouse uterus prior to implantation results in decreased 
formation of pinopods, projections from nonciliated endometrial epithelium that are as-
sociated with implantation success (Bagot et al., 2001). Pinopods have been documented 
in viviparous, but not oviparous reptiles, and different isoforms of Hoxa10-like proteins 
were found in the adult oviducts of an oviparous lizard (Lampropholis guichenoti) and a 
viviparous lizard (Eulamprus tympanum) (Thomson, 2006; Thomson et al., 2005). Under 
this hypothesis of uterine Hoxa10 expression being associated with viviparity, consider-
ing the evolutionary Archosaurian lineage of alligators and other crocodilians, detecting 
Hoxa10 gene expression in the alligator FRT would be an interesting finding. 
I proposed to investigate regionalized Hox gene expression in the alligator MD 
using in situ hybridization when I was awarded a fellowship through the National Science 
Foundation and the Japan Society for the Promotion of Science to work in the laboratory 
of Dr. Taisen Iguchi. By utilizing a sample set from my experiments involving treatment 
with E2 and PPT, I planned to determine whether Hox genes were expressed in alligator 
MD at all, using the control samples, and then whether normal expression patterns were 
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altered by estrogenic treatment. Unfortunately, I was not issued the necessary CITES per-
mit to export alligator tissues to Japan in time, and without the expertise of my Japanese 
colleagues I was unable to complete this experiment. I believe this remains an intriguing 
and potentially highly informative area for further research into the development of the 
alligator FRT.
5.3. Conclusions
As an intial foray into a complex developmental process in a non-model species 
from a complex environment, this study had its limitations, but still provides some valu-
able insights into potential regulatory mechanisms involved in alligator FRT differentia-
tion. The discovery that the alligator MD can be influenced to precocious glandulogenesis 
by developmental exposure to PPT is significant for its novelty in the alligator, particu-
larly because it demonstrates a bias of signaling through ERα in the differentiation of the 
FRT. The experiments described in this dissertation support the hypothesis that stimula-
tion of ERα via a selective agonist, without effective ERβ stimulation to play a regulatory 
role, induces proliferation and differentiation in the MD.  While these experiments did not 
clearly define the role of signaling through ERβ in regulating the proliferative and differ-
entiative effects of ERα signaling on alligator FRT differentiation, they provided support-
ive evidence that the effects of PPT are most likely due to its selective ERα activation 
rather than non-target effects of this compound.
 As with any scientific investigation, this dissertation produced more questions 
than it answered, particularly by illuminating the gaps in the general understanding of the 
normal process of FRT differentiation in alligators, and even all other vertebrates evalu-
ated for comparative purposes. It seems that the convention of considering reproductive 
tract differentiation to be “default,” simply an accessory to gonadal differentiation, is 
short-sighted. There are important signaling factors known to be involved in regulating 
regional patterning of the FRT, and there is strong evidence that these factors are regu-
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lated by steroid hormone signaling. The role of endocrine signaling in the developmental 
differentiation of the MD to the regionally specialized structures of the mature FRT is 
clouded by the role of endocrine signaling in the reproductively mature FRT itself, as it 
must be remarkably plastic and hormone-responsive in order to dramatically increase 
in size and provide the necessary components for fertilized eggs to develop into healthy 
offspring.  This means that estrogen signaling can play a different role in the embryonic 
development of the FRT than in the later remodeling of the reproductively active FRT, 
which makes it difficult to draw conclusions from experiments involving treatment of 
developing embryos with exogenous estrogens.  
 All in all, the female reproductive tract is evolutionarily and developmentally 
remarkable: it originates as a very simple tube composed of two cell types, and under the 
influence of a proper signaling environment, transforms into a structure of specialized re-
gional functionality that is capable of packaging offspring into a protected, nutrient-filled 
environment or directly connecting offspring to the mother’s body for developmental nur-
turing. In short, a properly functioning FRT is crucial for producing healthy offspring, and 
proper functioning of the FRT is reliant on proper developmental patterning. The modern 
world has put this process in jeopardy, with the prevalence and ubiquity of EDCs released 
into the environment. If we are to protect the future of life on this planet, our only re-
course is to seek greater understanding of the fundamental “normal” processes guiding 
the development of the FRT, in order to protect these processes against “abnormal.” 
85
REFERENCES
Akbas, G., Song, J., Taylor, H., 2004. A HOXA10 estrogen response element (ERE) is 
differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES). J Mol Biol. 340, 
1013-1023.
Andrews, G.K., Teng, C.S., 1979. Studies on sex-organ development. Prenatal effect of 
oestrogenic hormone on tubular-gland cell morphogenesis and ovalbumin-gene expres-
sion in the chick Müllerian duct. Biochem J 182, 271-286.
Austin, H.B., 1989. The effects of estradiol and testosterone on Müllerian-duct regression 
in the American alligator (Alligator mississippiensis). Gen Comp Endocrinol 76, 461-472.
Austin, H.B., 1991. The effects of norethindrone on the Müllerian ducts of the American 
alligator. Gen Comp Endocrinol 84, 300-307.
Bagot, C.N., Kliman, H.J., Taylor, H.S., 2001. Maternal Hoxa10 is required for pinopod 
formation in the development of mouse uterine receptivity to embryo implantation. Dev 
Dyn 222, 538-544.
Bagwill, A., Sever, D.M., Elsey, R.M., 2009. Seasonal variation of the oviduct of the 
American alligator, Alligator mississippiensis (Reptilia: Crocodylia). J Morphol 270, 702-
713.
Bancroft, J., Gamble, M., 2008. Theory and Practice of Histological Techniques, 6 ed. 
Churchill Livingstone, London.
Berg, C., Halldin, K., Fridolfsson, A.K., Brandt, I., Brunstrom, B., 1999. The avian egg as 
a test system for endocrine disrupters: effects of diethylstilbestrol and ethynylestradiol on 
sex organ development. Sci Total Environ 233, 57-66.
Berg, C., Holm, L., Brandt, I., Brunstrom, B., 2001. Anatomical and histological changes 
in the oviducts of Japanese quail, Coturnix japonica, after embryonic exposure to ethyny-
loestradiol. Reproduction 121, 155-165.
Bern, H.A., 1992. The fragile fetus, in: Colborn, T., Clement, C. (Eds.), Chemically-In-
duced Alterations in Sexual and Functional Development: The Wildlife/Human Connec-
tion. Princeton Scientific Publishing Co, Inc., Princeton, NJ.
Bitman, J., Cecil, H., Harris, S., Fries, G., 1969. DDT induces a decrease in eggshell cal-
cium. Nature 224, 44-46.
Block, K., Kardana, A., Igarashi, P., Taylor, H., 2000. In utero diethylstilbestrol (DES) 
exposure alters Hox gene expression in the developing müllerian system. FASEB J 14, 
1101-1108.
86
Blus, L., Neely, B., Jr. , Belisle, A., Prouty, R., 1974. Organochlorine residues in brown 
pelican eggs: relation to reproductive success. Environ Pollut 7, 81-91.
Brunstrom, B., Axelsson, J., Mattsson, A., Halldin, K., 2009. Effects of estrogens on sex 
differentiation in Japanese quail and chicken. Gen Comp Endocrinol 163, 97-103.
Bryan, T., 2005. Morphology and constituent analyses of American alligator (Alligator 
mississippiensis) eggshells from contaminated and reference lakes. Master’s thesis. Uni-
versity of Florida, Gainesville, FL.
Buhi, W.C., Alvarez, I.M., Binelli, M., Walworth, E.S., Guillette, L.J., Jr., 1999. Identi-
fication and characterization of proteins synthesized de novo and secreted by the repro-
ductive tract of the American alligator, Alligator mississippiensis. J Reprod Fertil 115, 
201-213.
Bull, J.J., Gutzke, W.H., Crews, D., 1988. Sex reversal by estradiol in three reptilian or-
ders. Gen Comp Endocrinol 70, 425-428.
Colborn, T., Bern, H., Blair, P., Brasseur, S., Cunha, G.R., Davis, W., Dohler, K., Fox, G., 
Fry, M., Gray, E., Green, R.E., Hines, M., Kubiak, T., McLachlan, J., Myers, J.P., Peter-
son, R., Reijnders, P., Soto, A.M., Van der Kraak, G., vom Saal, F.S., Whitten, P., 1992. 
Statement from the work session, in: Colborn, T., Clement, C. (Eds.), Chemically-In-
duced Alterations in Sexual and Functional Development: The Wildlife/Human Connec-
tion. Princeton Scientific Publishing Co., Inc., Princeton, NJ.
Colborn, T., Dumanoski, D., Myers, J.P., 1996. Our Stolen Future. Penguin Books USA, 
Inc., New York.
Conrow, R., Lowe, E.F., Coveney, M.F., Rauschenberger, R.H., Masson, G., 2011. Res-
toration of Lake Apopka’s north shore marsh: high hopes, tough times, and persistent 
progress, in: Elliott, J.E., Bishop, C.A., Morrissey, C.A. (Eds.), Wildlife Ecotoxicology: 
Forensic Approaches. Springer New York, pp. 189-211.
Cooke, A., 1973. Shell thinning in avian eggs by environmental pollution. Environ Pollut 
4, 85-152.
Couse, J.F., Korach, K.S., 2004. Estrogen receptor-alpha mediates the detrimental effects 
of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract. Toxicolo-
gy 205, 55-63.
Cox, C., Guillette, L.J., Jr., 1993. Localization of insulin-like growth factor-I-like im-
munoreactivity in the reproductive tract of the vitellogenic female American alligator, 
Alligator mississippiensis. Anat Rec 236, 635-640.
Cox, M.C., 1994. Presence and functional role of the polypeptide growth factors insu-
lin-like growth factor I (IGF-I) and epidermal growth factor (EGF) in the reptilian ovi-
duct. PhD dissertation. University of Florida, Gainesville, FL.
87
Crain, D.A., Guillette, L.J., Jr., Rooney, A.A., Pickford, D.B., 1997. Alterations in ste-
roidogenesis in alligators (Alligator mississippiensis) exposed naturally and experimen-
tally to environmental contaminants. Environ Health Perspect 105, 528-533.
Crain, D.A., Janssen, S.J., Edwards, T.M., Heindel, J., Ho, S.M., Hunt, P., Iguchi, T., Juul, 
A., McLachlan, J.A., Schwartz, J., Skakkebaek, N., Soto, A.M., Swan, S., Walker, C., 
Woodruff, T.K., Woodruff, T.J., Giudice, L.C., Guillette, L.J., Jr., 2008. Female reproduc-
tive disorders: the roles of endocrine-disrupting compounds and developmental timing. 
Fertil Steril 90, 911-940.
Crain, D.A., Spiteri, I.D., Guillette, L.J., Jr., 1999. The functional and structural observa-
tions of the neonatal reproductive system of alligators exposed in ovo to atrazine, 2,4-D, 
or estradiol. Toxicol Ind Health 15, 180-185.
Deeming, D.C., Ferguson, M.W.J., Mittwoch, U., Wolf, U., Dorizzi, M., Zaborski, P., 
Sharma, H., 1988. Environmental regulation of sex determination in reptiles. Philos Trans 
R Soc Lond B Biol Sci 322, 19-39.
DiAugustine, R.P., P., P., Bell, G.I., Brown, C.F., -, B.C.F., Korach, K.S., McLachlan, 
J.A., Teng, C.T., 1988. Influence of estrogens on mouse uterine epidermal growth factor 
precursor protein and messenger ribonucleic acid. Endocrinology 122, 2355-2363.
Doheny, B.M., Kohno, S., Guillette, L.J., Jr., 2016. In ovo treatment with an estrogen 
receptor alpha selective agonist causes precocious development of the female reproduc-
tive tract of the American alligator (Alligator mississippiensis). Gen Comp Endocrinol, 
10.1016/j.ygcen.2016.1002.1026.
Dougherty, D.C., Sanders, M.M., 2005. Estrogen action: revitalization of the chick ovi-
duct model. Trends Endocrinol Metab 16, 414-419.
Elbrecht, A., Smith, R.G., 1992. Aromatase enzyme activity and sex determination in 
chickens. Science 255, 467-470.
Emmen, J.M., Korach, K.S., 2003. Estrogen receptor knockout mice: phenotypes in the 
female reproductive tract. Gynecol Endocrinol 17, 169-176.
Ferguson, M.W., Joanen, T., 1982. Temperature of egg incubation determines sex in Alli-
gator mississippiensis. Nature 296, 850-853.
Ferguson, M.W.J., 1985. Reproductive biology and embryology of the crocodilians in: 
Gans, C., Billet, F., Maderson, P.F.A. (Eds.), Biology of the Reptilia. John Wiley and 
Sons, New York, pp. 329-491.
Forbes, T.R., 1938a. Administration of oestrone to young alligators. Science 87, 282-283.
Forbes, T.R., 1938b. Studies on the reproductive system of the alligator. II. The effects of 
prologed injections of oestrone in the immature alligator. J. Exp. Zool. 78, 335-367.
88
Forbes, T.R., 1940. Studies on the reproductive system of the alligator. IV. Observations 
on the development of the gonad, the adrenal cortex, and the Müllerian duct. Contrib 
Embryol 174, 131-154.
Fu, Z., Kubo, T., Noguchi, T., Kato, H., 2001. Developmental changes in the mRNA lev-
els of IGF-I and its related genes in the reproductive organs of Japanese quail (Coturnix 
coturnix japonica). Growth Horm IGF Res 11, 24-33.
Gilbert, S.F., 2000. Developmental Biology, 6th ed. Sinauer Associates, Sunderland, MA.
Grier, J.W., 1982. Ban of DDT and subsequent recovery of reproduction in bald eagles. 
Science 218, 1232-1235.
Guillette, L.J., Jr., 1991. The evolution of viviparity in amniote vertebrates: new insights, 
new questions. J Zool., Lond. 223, 521-526.
Guillette, L.J., Jr., 1992. Reproductive biology of the female alligator. Florida Game and 
Freshwater Fish Commission, Gainesville, FL.
Guillette, L.J., Jr., Crain, D.A., Gunderson, M.P., Kools, S.A.E., Milnes, M.R., Orlando, 
E.F., Rooney, A.A., Woodward, A.R., 2000. Alligators and endocrine disrupting contami-
nants: a current perspective. Am Zool 40, 438-452.
Guillette, L.J., Jr., Gross, T.S., Masson, G.R., Matter, J.M., Percival, H.F., Woodward, 
A.R., 1994. Developmental abnormalities of the gonad and abnormal sex hormone con-
centrations in juvenile alligators from contaminated and control lakes in Florida. Environ 
Health Perspect 102, 680-688.
Guillette, L.J., Jr., Moore, B.C., 2006. Environmental contaminants, fertility, and multio-
ocytic follicles: a lesson from wildlife? Semin Reprod Med 24, 134-141.
Guillette, L.J., Jr., Pickford, D.B., Crain, D.A., Rooney, A.A., Percival, H.F., 1996. Re-
duction in penis size and plasma testosterone concentrations in juvenile alligators living 
in a contaminated environment. Gen Comp Endocrinol 101, 32-42.
Guillette, L.J., Jr., Woodward, A.R., Crain, D.A., Masson, G.R., Palmer, B.D., Cox, M.C., 
You-Xiang, Q., Orlando, E.F., 1997. The reproductive cycle of the female American alli-
gator (Alligator mississippiensis). Gen Comp Endocrinol 108, 87-101.
Halldin, K., 2005. Impact of endocrine disrupting chemicals on reproduction in Japanese 
quail. Domest Anim Endocrinol 29, 420-429.
Hamilton, T.H., 1961. Studies on the physiology of urogenital differentiation in the chick 
embryo. I. Hormonal control of sexual differentiation of Müllerian ducts. J Exp Zool 146, 
265-274. 
89
Hamlin, H.J., Guillette, L.J., Jr., 2011. Embryos as targets of endocrine disrupting con-
taminants in wildlife. Birth Defects Res C Embryo Today 93, 19-33.
Heinz, G.H., Percival, H.F., Jennings, M.L., 1991. Contaminants in American alligator 
eggs from Lake Apopka, Lake Griffin, and Lake Okeechobee, Florida. Environ Monit 
Assess 16, 277-285.
Helguero, L.A., Faulds, M.H., Gustafsson, J.A., Haldosen, L.A., 2005. Estrogen receptors 
alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the 
normal murine mammary epithelial cell line HC11. Oncogene 24, 6605-6616.
Herbst, A.L., Ulfelder, H., Poskanzer, D.C., 1971. Adenocarcinoma of the vagina. Asso-
ciation of maternal stilbestrol therapy with tumor appearance in young women. N Engl J 
Med 284, 878–881.
Hermansson, A., 2007. Effects on the reproductive system in domestic fowl (Gallus do-
mesticus) after embryonic exposure to estrogenic substances. PhD dissertation. Swedish 
University of Agricultural Sciences, Uppsala, Sweden.
Hewitt, S.C., Li, Y., Li, L., Korach, K.S., 2010. Estrogen-mediated regulation of Igf1 
transcription and uterine growth involves direct binding of estrogen receptor alpha to 
estrogen-responsive elements. J Biol Chem 285, 2676-2685.
Holm, L., Blomqvist, A., Brandt, I., Brunstrom, B., Ridderstrale, Y., Berg, C., 2006. Em-
bryonic exposure to o,p’-DDT causes eggshell thinning and altered shell gland carbonic 
anhydrase expression in the domestic hen. Environ Toxicol Chem 25, 2787-2793.
Hsieh-Li, H.M., Witte, D.P., Weinstein, M., Branford, W., Li, H., Small, K., Potter, S.S., 
1995. Hoxa 11 structure, extensive antisense transcription, and function in male and fe-
male fertility. Development 121, 1373-1385.
Humason, G.L., 1979. Animal Tissue Techniques. W.H. Freeman, San Francisco.
Hutchinson, T.H., Madden, J.C., Naidoo, V., Walker, C.H., 2014. Comparative metabo-
lism as a key driver of wildlife species sensitivity to human and veterinary pharmaceuti-
cals. Philos Trans R Soc Lond B Biol Sci 369.
Hutson, J.M., Donahoe, P.K., MacLaughlin, D.T., 1985. Steroid modulation of Müllerian 
duct regression in the chick embryo. Gen Comp Endocrinol 57, 88-102.
Hutson, J.M., MacLaughlin, D.T., Ikawa, H., Budzik, G.P., Donahoe, P.K., 1983. Regres-
sion of the Mullerian ducts during sexual differentiation in the chick embryo. A reapprais-




Iguchi, T., 2000. Embryonic and neonatal exposure to endocrine-altering contaminants: 
effects on mammalian female reproduction, in: Guillette, L.J., Jr., Crain, D.A. (Eds.), En-
vironmental Endocrine Disruptors: An Evolutionary Perspective. Taylor & Francis, New 
York, NY, USA, pp. 234-268.
Johnson, A.L., 1986. Reproduction in the female, in: Sturkie, P.D. (Ed.), Avian Physiolo-
gy. Springer New York, New York, NY, pp. 403-431.
Kamata, R., Shiraishi, F., Takahashi, S., Shimizu, A., Shiraishi, H., 2009. Reproductive 
and developmental effects of transovarian exposure to o,p’-DDT in Japanese quails. Envi-
ron Toxicol Chem 28, 782-790.
Katsu, Y., Bermudez, D.S., Braun, E.L., Helbing, C., Miyagawa, S., Gunderson, M.P., 
Kohno, S., Bryan, T.A., Guillette, L.J., Jr., Iguchi, T., 2004. Molecular cloning of the es-
trogen and progesterone receptors of the American alligator. Gen Comp Endocrinol 136, 
122-133.
Katsu, Y., Matsubara, K., Kohno, S., Matsuda, Y., Toriba, M., Oka, K., Guillette, L.J., Jr., 
Ohta, Y., Iguchi, T., 2010. Molecular cloning, characterization, and chromosome mapping 
of reptilian estrogen receptors. Endocrinology 151, 5710-5720.
Katzenellenbogen, B.S., Choi, I., Delage-Mourroux, R., Ediger, T.R., Martini, P.G., 
Montano, M., Sun, J., Weis, K., Katzenellenbogen, J.A., 2000a. Molecular mechanisms 
of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol 
Biol 74, 279-285.
Katzenellenbogen, B.S., Montano, M.M., Ediger, T.R., Sun, J., Ekena, K., Lazennec, G., 
Martini, P.G., McInerney, E.M., Delage-Mourroux, R., Weis, K., Katzenellenbogen, J.A., 
2000b. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. 
Recent Prog Horm Res 55, 163-193.
Katzenellenbogen, J.A., 1995. The structural pervasiveness of estrogenic activity. Envi-
ron Health Perspect 103 Suppl 7, 99-101.
Kida, S., Iwaki, M., Nakamura, A., Miura, Y., Takenaka, A., Takahashi, S.I., Noguchi, 
T., 1994. Insulin-like growth factor-1 messenger RNA content in the oviduct of Japanese 
quail (Coturnix coturnix japonica): changes during growth and development or after es-
trogen administration. Comp. Biochem. Physiol. C-Pharmacol. Toxicol. Endocrinol. 109, 
191-204.
Kobayashi, A., Behringer, R.R., 2003. Developmental genetics of the female reproductive 
tract in mammals. Nat Rev Genet 4, 969-980.
Kohler, P.O., Grimley, P.M., O’Malley, B.W., 1969. Estrogen-induced cytodifferentiation 
of the ovalbumin-secreting glands of the chick oviduct. J Cell Biol 40, 8-27. 
91
Kohno, S., Bermudez, D.S., Katsu, Y., Iguchi, T., Guillette, L.J., Jr., 2008. Gene expres-
sion patterns in juvenile American alligators (Alligator mississippiensis) exposed to envi-
ronmental contaminants. Aquat Toxicol 88, 95-101.
Kohno, S., Bernhard, M.C., Katsu, Y., Zhu, J., Bryan, T.A., Doheny, B.M., Iguchi, T., 
Guillette, L.J., Jr., 2015. Estrogen Receptor 1 (ESR1; ERalpha), not ESR2 (ERbeta), 
modulates estrogen-induced sex reversal in the American alligator, a species with tem-
perature-dependent sex determination. Endocrinology 156, 1887-1899.
Kohno, S., Guillette, L.J., Jr., 2013. Endocrine disruption and reptiles: Using the unique 
attributes of temperature-dependent sex determination to assess impacts, in: Matthiessen, 
P. (Ed.), Endocrine disrupters: Hazard testing and assessment methods. John Wiley, Sons, 
Hoboken, NJ, pp. 245–271.
Kojima, H., Katsura, E., Takeuchi, S., Niiyama, K., Kobayashi, K., 2003. Screening for 
estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene as-
says using chinese hamster ovary cells. Environ Health Perspect 112, 524-531.
Krishna, T.S., Kong, X.P., Gary, S., Burgers, P.M., Kuriyan, J., 1994. Crystal structure of 
the eukaryotic DNA polymerase processivity factor PCNA. Cell 79, 1233-1243.
Krumlauf, R., 1994. Hox genes in vertebrate development. Cell 78, 191-201.
Kurita, T., 2011. Normal and abnormal epithelial differentiation in the female reproduc-
tive tract. Differentiation 82, 117-126.
Lance, V.A., 2003. Alligator physiology and life history: the importance of temperature. 
Exp Gerontol 38, 801-805.
Lance, V.A., Bogart, M.H., 1992. Disruption of ovarian development in alligator embryos 
treated with an aromatase inhibitor. Gen Comp Endocrinol 86, 59-71.
Lang, J.W., Andrews, H.V., 1994. Temperature-dependent sex determination in crocodil-
ians. J Exp Zool 270, 28-44.
Li, Y., Burns, K.A., Arao, Y., Luh, C.J., Korach, K.S., 2012. Differential estrogenic 
actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone 
through estrogen receptor alpha and beta in vitro. Environ Health Perspect 120, 1029-
1035.
Lundholm, C.D., 1997. DDE-induced eggshell thinning in birds: effects of p,p’-DDE on 
the calcium and prostaglandin metabolism of the eggshell gland. Comp Biochem Physiol 
C Pharmacol Toxicol Endocrinol 118, 113-128.
Ma, L., Benson, G.V., Lim, H., Dey, S.K., Maas, R.L., 1998. Abdominal B (AbdB) Hoxa 
genes: regulation in adult uterus by estrogen and progesterone and repression in Mülleri-
an duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 197, 141-154.
92
MacLaughlin, D.T., Hutson, J.M., Donahoe, P.K., 1983. Specific estradiol binding in 
embryonic Müllerian ducts: a potential modulator of regression in the male and female 
chick. Endocrinology 113, 141-145.
Matthews, J., Gustafsson, J.A., 2003. Estrogen signaling: a subtle balance between ER 
alpha and ER beta. Mol Interv 3, 281-292.
Mattsson, A., 2008. Roles of ERα and ERβ in normal and disrupted sex differentiation in 
Japanese quail. PhD dissertation. Uppsala Universitet, Uppsala, Sweden.
Mattsson, A., Olsson, J.A., Brunstrom, B., 2011. Activation of estrogen receptor alpha 
disrupts differentiation of the reproductive organs in chicken embryos. Gen Comp Endo-
crinol 172, 251-259.
McCoy, J.A., Parrott, B.B., Rainwater, T.R., Wilkinson, P.M., Guillette, L.J., Jr., 2015. 
Incubation history prior to the canonical thermosensitive period determines sex in the 
American alligator. Reproduction 150, 279-287.
Milnes, M.R., Bryan, T.A., Katsu, Y., Kohno, S., Moore, B.C., Iguchi, T., Guillette, L.J., 
Jr., 2008. Increased posthatching mortality and loss of sexually dimorphic gene expres-
sion in alligators (Alligator mississippiensis) from a contaminated environment. Biol 
Reprod 78, 932-938.
Milnes, M.R., Bryan, T.A., Medina, J.G., Gunderson, M.P., Guillette, L.J., Jr., 2005. 
Developmental alterations as a result of in ovo exposure to the pesticide metabolite p,p’-
DDE in Alligator mississippiensis. Gen Comp Endocrinol 144, 257-263.
Milnes, M.R., Guillette, L.J., Jr. , 2008. Alligator tales: new lessons about environmental 
contaminants from a sentinel species. Bioscience 58, 1027.
Moore, B.C., Forouhar, S., Kohno, S., Botteri, N.L., Hamlin, H.J., Guillette, L.J., Jr., 
2012. Gonadotropin-induced changes in oviducal mRNA expression levels of sex steroid 
hormone receptors and activin-related signaling factors in the alligator. Gen Comp Endo-
crinol 175, 251-258.
Moore, B.C., Kohno, S., Cook, R.W., Alvers, A.L., Hamlin, H.J., Woodruff, T.K., Guil-
lette, L.J., 2010a. Altered sex hormone concentrations and gonadal mRNA expression 
levels of activin signaling factors in hatchling alligators from a contaminated Florida 
lake. J Exp Zool A Ecol Genet Physiol 313A, 218-230.
Moore, B.C., Milnes, M.R., Kohno, S., Katsu, Y., Iguchi, T., Guillette, L.J., Jr., 2010b. 
Influences of sex, incubation temperature, and environmental quality on gonadal estrogen 
and androgen receptor messenger RNA expression in juvenile American alligators (Alli-
gator mississippiensis). Biol Reprod 82, 194-201. 
 
93
Moore, B.C., Milnes, M.R., Kohno, S., Katsu, Y., Iguchi, T., Woodruff, T.K., Guillette, 
L.J., Jr., 2011. Altered gonadal expression of TGF-beta superfamily signaling factors in 
environmental contaminant-exposed juvenile alligators. J Steroid Biochem Mol Biol 127, 
58-63.
Munro, S.S., Kosin, T.L., 1943. Dramatic response of the chick oviduct to estrogen. Poult 
Sci, 330-331.
Murphy, L.J., L.C., M., Friesen, H.G., 1987. Estrogen induces insulin-like growth factor-I 
expression in the rat uterus. Mol Endocrinol 1, 445-450.
Nakamura, T., Katsu, Y., Watanabe, H., Iguchi, T., 2008. Estrogen receptor subtypes se-
lectively mediate female mouse reproductive abnormalities induced by neonatal exposure 
to estrogenic chemicals. Toxicology 253, 117-124.
Newbold, R.R., 2004. Lessons learned from perinatal exposure to diethylstilbestrol. Toxi-
col Appl Pharmacol 199, 142-150.
Norris, D.O., 1997. Vertebrate Endocrinology, 3rd ed. Academic Press, Inc., San Diego, 
CA, USA.
Oka, T., Schimke, R.T., 1969a. Interaction of estrogen and progesterone in chick oviduct 
development. I. Antagonistic effect of progesterone on estrogen-induced proliferation and 
differentiation of tubular gland cells. J Cell Biol 41, 816-831.
Oka, T., Schimke, R.T., 1969b. Interaction of estrogen and progesterone in chick oviduct 
development. II. Effects of estrogen and progesterone on tubular gland cell function. J 
Cell Biol 43, 123-137.
Oriowo, M.A., Landgren, B.M., Stenstrom, B., Diczfalusy, E., 1980. A comparison of the 
pharmacokinetic properties of three estradiol esters. Contraception 21, 415-424.
Palmer, B.D., 1990. Functional morphology and biochemistry of reptilian oviducts and 
eggs: implications for the evolution of reproductive modes in tetrapod vertebrates. PhD 
dissertation. University of Florida, Gainesville, FL.
Palmer, B.D., Guillette, L.J., Jr., 1992. Alligators provide evidence for the evolution of an 
archosaurian mode of oviparity. Biol Reprod 46, 39-47.
Palmiter, R.D., Wrenn, J.T., 1971. Interaction of estrogen and progesterone in chick ovi-
duct development. 3. Tubular gland cell cytodifferentiation. J Cell Biol 50, 598-615.
Ramsey, M., Crews, D., 2009. Steroid signaling and temperature-dependent sex determi-
nation-Reviewing the evidence for early action of estrogen during ovarian determination 
in turtles. Semin Cell Dev Biol 20, 283-292. 
94
Rauschenberger, R.H., Sepulveda, M.S., Wiebe, J.J., Szabo, N.J., Gross, T.S., 2004. 
Predicting maternal body burdens of organochlorine pesticides from eggs and evidence of 
maternal transfer in Alligator mississippiensis. Environ Toxicol Chem 23, 2906-2915.
Rauschenberger, R.H., Wiebe, J.J., Sepulveda, M.S., Scarborough, J.E., Gross, T.S., 2007. 
Parental exposure to pesticides and poor clutch viability in American alligators. Environ 
Sci Technol 41, 5559-5563.
Rider, C.V., Hartig, P.C., Cardon, M.C., Lambright, C.R., Bobseine, K.L., Guillette, L.J., 
Jr., Gray, L.E., Jr., Wilson, V.S., 2010. Differences in sensitivity but not selectivity of 
xenoestrogen binding to alligator versus human estrogen receptor alpha. Environ Toxicol 
Chem 29, 2064-2071.
Rissman, E.F., Ascenzi, M., Johnson, P., Adkins-Regan, E., 1984. Effect of embryonic 
treatment with oestradiol benzoate on reproductive morphology, ovulation and oviposi-
tion and plasma LH concentrations in female quail (Coturnix coturnix japonica). J Re-
prod Fertil 71, 411-417.
Rooney, A.A., Crain, D.A., Woodward, A.R., Guillette, L.J., Jr., 2004. Seasonal variation 
in plasma sex steroid concentrations in juvenile American alligators. Gen Comp Endocri-
nol 135, 25-34.
Satokata, I., Benson, G., Maas, R., 1995. Sexually dimorphic sterility phenotypes in 
Hoxa10-deficient mice. Nature 374, 460-463.
Sepehr, E., Lebl-Rinnova, M., Mann, M.K., Pisani, S.L., Churchwell, M.I., Korol, D.L., 
Katzenellenbogen, J.A., Doerge, D.R., 2012. Pharmacokinetics of the estrogen recep-
tor subtype-selective ligands, PPT and DPN: quantification using UPLC-ES/MS/MS. J 
Pharm Biomed Anal 71, 119-126.
Smith, C.A., Joss, J.M.P., 1993. Gonadal sex differentiation in Alligator mississippiensis, 
a species with temperature-dependent sex determination. Cell Tissue Res 273, 149-162.
Smith, C.A., Roeszler, K.N., Ohnesorg, T., Cummins, D.M., Farlie, P.G., Doran, T.J., Sin-
clair, A.H., 2009. The avian Z-linked gene DMRT1 is required for male sex determination 
in the chicken. Nature 461, 267-271.
St John, J.A., Braun, E.L., Isberg, S.R., Miles, L.G., Chong, A.Y., Gongora, J., Dalzell, 
P., Moran, C., Bed’hom, B., Abzhanov, A., Burgess, S.C., Cooksey, A.M., Castoe, T.A., 
Crawford, N.G., Densmore, L.D., Drew, J.C., Edwards, S.V., Faircloth, B.C., Fujita, 
M.K., Greenwold, M.J., Hoffmann, F.G., Howard, J.M., Iguchi, T., Janes, D.E., Khan, 
S.Y., Kohno, S., de Koning, A.J., Lance, S.L., McCarthy, F.M., McCormack, J.E., Mer-
chant, M.E., Peterson, D.G., Pollock, D.D., Pourmand, N., Raney, B.J., Roessler, K.A., 
Sanford, J.R., Sawyer, R.H., Schmidt, C.J., Triplett, E.W., Tuberville, T.D., Venegas-An-
aya, M., Howard, J.T., Jarvis, E.D., Guillette, L.J., Jr., Glenn, T.C., Green, R.E., Ray, 
D.A., 2012. Sequencing three crocodilian genomes to illuminate the evolution of archo-
saurs and amniotes. Genome Biol 13, 415.
95
Taylor, H.S., 2000. The role of HOX genes in the development and function of the female 
reproductive tract. Semin Reprod Med 18, 81-89.
Taylor, H.S., Vanden Heuvel, G.B., Igarashi, P., 1997. A conserved Hox axis in the mouse 
and human female reproductive system: late establishment and persistent adult expression 
of the Hoxa cluster genes. Biol Reprod 57, 1338-1345.
Thomson, M., 2006. Review: HoxA10 and the transition from oviparity to viviparity. 
Herpetological Monographs 20, 212-218.
Thomson, M., Herbert, J.F., Murphy, C.R., Thompson, M.B., 2005. HoxA10-like proteins 
in the reproductive tract of the viviparous lizard Eulamprus tympanum and the oviparous 
lizard Lampropholis guichenoti. Comparative biochemistry and physiology. Part B, Bio-
chemistry & molecular biology 142, 123-127.
Thornton, J.W., 2001. Evolution of vertebrate steroid receptors from an ancestral estrogen 
receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci U S A 
98, 5671-5676.
Turusov, V., Rakitsky, V., Tomatis, L., 2002. Dichlorodiphenyltrichloroethane (DDT): 
ubiquity, persistence, and risks. Environ Health Perspect 110, 125-128.
United States Centers for Disease Control and Prevention, 2011. CDC’s DES update. 
http://www.cdc.gov/des.
United States Environmental Protection Agency, 1994. Tower Chemical Company Super-
fund Site Biological Assessment. USEPA Region IV, Athens (GA).
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., Spele-
man, F., 2002. Accurate normalization of real-time quantitative RT-PCR data by geomet-
ric averaging of multiple internal control genes. Genome Biol 3, 1-11.
vom Saal, F.S., Montano, M., Ming, H.W., 1992. Sexual differentiation in mammals, in: 
Colborn, T., Clement, C. (Eds.), Chemically-Induced Alterations in Sexual and Function-
al Development: The WIldlife/Human Connection. Princeton Scientific Publishing Co., 
Inc., Princeton, NJ.
Vonier, P.M., Crain, D.A., McLachlan, J.A., Guillette, L.J., Jr., Arnold, S.F., 1996. Inter-
action of environmental chemicals with the estrogen and progesterone receptors from the 
oviduct of the American alligator. Environ Health Perspect 104, 1318-1322.
Wilkinson, P., Rhodes, W., 1997. Growth rates of American alligators in coastal South 
Carolina. J Wildl Manage 61, 397-402.
Willier, B.H., Gallagher, T.F., Koch, F.C., 1937. The modification of sex development in 
the chick embryo by male and female sex hormones. Physiol Zool 10, 101-122.
96
Witschi, E., 1935. Origin of asymmetry in the reproductive system of birds. Am J Anat 
56, 119-141.
Woods, J.E., Brazzill, D.M., 1981. Plasma 17 beta-estradiol levels in the chick embryo. 
Gen Comp Endocrinol 44, 37-43.
Woodward, A.R., Percival, H.F., Jennings, M.L., Moore, C.T., 1993. Low clutch viability 
in American alligators on Lake Apopka. Fla Sci 56, 52-64.
Woodward, A.R., Percival, H.F., Rauschenberger, R.H., Gross, T., Rice, K., Conrow, R., 
2011. Abnormal alligators and organochlorine pesticides in Lake Apopka, Florida, in: 
Elliott, J.E., Bishop, C.A., Morrissey, C.A. (Eds.), Wildlife Ecotoxicology: Forensic Ap-
proaches. Springer New York, pp. 153-187.




 Brenna Mary Doheny was born March 16, 1981, in Minneapolis, Minnesota, but 
at age 7 her family relocated to the sunny beaches of Northwest Florida. Brenna spent a 
good part of her childhood snorkeling in the bayou in her backyard, kindling a lifelong 
interest in marine biology. Her love of learning led her to strong academic achievement 
in the International Baccalaureate Program at her high school, and she graduated summa 
cum laude. Brenna postponed college in favor of accepting a Congress-Bundestag Youth 
Exchange Program scholarship to spend a year as an exchange student at the Gymnasium 
Neue Oberschule in Braunschweig, Germany, where she cultivated fluency in the German 
language and a love of traveling and experiencing new cultures.
 Upon returning to the U.S., Brenna began studying biology at the University of 
West Florida, and in the summer following her freshman year, she began an internship 
with the U.S. EPA through their Science Training in Ecology Program, under the mentor-
ship of William P. Davis. This internship was her introduction to the field of environmen-
tal endocrine disruption, which quickly became her greatest scientific passion. 
 Funding cuts led to the termination of the STEP program, however, and seeing a 
lack of other interesting research opportunities at UWF, Brenna began attending Oregon 
State University through the National Student Exchange program. She spent an academic 
quarter at OSU’s Hatfield Marine Science Center and interned with NOAA’s National 
Marine Fisheries Service, studying pathogen transmission in juvenile salmon. She ar-
ranged a summer research internship with Jean Joss at Macquarie University in Sydney, 
Australia, investigating the evolution of tetrapod limb development with Australian lung-
fish. 
Brenna transferred to OSU to finish her B.S. in biology, and added a B.A. in 
German in order to maintain her language skills. She pursued a side interest in science 
journalism as a reporter and editor for the student-run daily campus newspaper, and 
won a regional award for her writing. She also pursued her interest in public outreach in 
98
environmental health and sustainability, and started a community research and advoca-
cy group promoting the use of biodiesel. This group was awarded a grant from the U.S. 
EPA to present their work at an event on the National Mall in Washington, D.C. As part 
of their presentation, Brenna and two fellow group members drove all the way across the 
country to this event in her 1978 diesel engine Mercedes 300D, fueled by biodiesel. 
After graduating magna cum laude from OSU, Brenna followed her sense of 
“Wanderlust” to Austria, where she spent two years as an English teaching assistant 
through the Fulbright program.  By the end of this time spent honing her language and 
teaching skills while exploring Europe, it was time to return to her passion for endocrine 
disruption research. She entered the PhD program in Marine Biomedicine and Environ-
mental Sciences at the Medical University of South Carolina under the mentorship of 
Louis J. Guillette, Jr., one of her personal heroes.  
While pursuing her dissertation research on the developing female reproduc-
tive tract in the American alligator, Brenna served as a teaching assistant at the Citadel 
through the Graduate Assistance in Areas of National Need grant program. She also 
mentored undergraduate researchers in the laboratory and helped to coordinate the MBES 
Summer Undergraduate Research Program. Brenna led the MBES Student Association 
in outreach events promoting education in environmental health issues, for which she 
received funding through the SC SEA Grant Consortium. 
In 2014, Brenna was awarded a fellowship through the NSF East Asia Pacific 
Summer Institutes and the Japan Society for the Promotion of Science Summer Program 
to spend 10 weeks in Japan, working in the laboratory of Taisen Iguchi, a longtime re-
search collaborator with Louis Guillette. 
 After being awarded her PhD from MUSC, Brenna will continue pursuing her 
passion for environmental health research and sharing this research through public out-
reach and science education. She plans to take advantage of any opportunities to travel 
and experience new cultures along the way.
